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Cholinesterase-inhibiting (ChE-I) pesticides, which include
both organophosphates (OP's) and carbamates, together constitute
a very significant proportion of pesticides used in the U.S.
and worldwide.  ChE-I pesticides are known to disrupt nervous
system functioning in animals and humans, and OP's are
implicated in human poisonings more often than any other
class of pesticides.  The U.S. Environmental Protection Agency
(EPA) uses ChE-I to characterize the risks of these pesticides
since ChE-I is a sensitive predictor of exposure.
Assessing the risks of OP's and carbamates on the basis
of ChE-I involves many uncertainties.  The decisions
and assumptions made to resolve these uncertainties are
science policy decisions, and can have a significant impact
on the final characterization of the risk.  This report
identifies the principal uncertainties throughout each of the
four stages of risk assessment (as described by the National
Research Council), discusses the nature and public health
implications of these uncertainties, suggests an approach for
describing and resolving uncertainties, and provides
recommendations useful in developing a science policy for ChE-
I pesticides.  It is concluded that the EPA's use of an uncertainty
factor as small as ten is not justified by the available
scientific evidence.
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I.   Introduction
Cholinesterase-inhibiting pesticides, which include organic
phosphorus pesticides (OPs) and carbamates, together constitute
over half of the total volume of insecticides used in the United
States (Doull, 1980), and a very significant proportion of pesti¬
cides used worldwide. In 1976 annual production of OPs exceeded
10^ Kg. OPs and carbamates have been rapidly replacing the
persistent chlorinated hydrocarbon pesticides (e.g. DDT, endrin,
kepone, toxaphene), most of which have been banned or severely
restricted.
Both OPs and carbamate compounds share an ability to inhibit
cholinesterases (ChEs), principally acetylcholinesterase (AChE)
in nerve tissue. AChE is an enzyme critically important to
central and peripheral nervous system functioning, which hydro-
lyzes acetylcholine (ACh), a neurotransmitter. OP pesticides had
their origins in 1937, when Germany developed extremely potent OP
compounds known as nerve gases (e.g., N-dimethyl phosphoramido-
cyanidate [tabun] and isopropyl methylphosphorofluoridate [sarin]
as potential chemical warfare agents, OP insecticides are impli¬
cated in more human poisoning than any other class of pesticides
(Doull, 1980).
Cholinesterase inhibition (ChE-I) is frequently considered
the most sensitive health endpoint; i.e., other effects (e.g.,
reproductive, ocular) which may be caused by these compounds,
generally occur at higher doses. As more sensitive methodologies
are developed, neurobehavioral effects may be found to be an even
more sensitive indication of exposure to Ch£-I pesticides, but at
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the present time no generally accepted means of assessing
neurobehavioral changes resulting from exposures to toxic
substances in human populations exists (Otto and Eckerman, 1985).
As the scientific data base on the risks associated with
these compounds has been developed and refined over the years, so
have the procedures for assessing and managing risk. The
National Research Council's Risk AaspRHmpn t-_ in thp Federal
Government: Managing the Process (1983) describes the most
recent approach (which EPA has adopted) for conducting and under¬
standing risk assessments (EPA, 1986).
Risk assessment, the largely scientific process of charac¬
terizing the potential adverse health effects resulting from
human exposure to environmental hazards, is distinguished from
risk management, the largely political process which considers
scientific factors from the risk assessment as well as economic,
legal, technological, administrative and other factors to
evaluate and select alternative regulatory actions. In this
approach, a risk assessment would usually include the following
four stages:
1) Hazard identification: What are the adverse health
effects associated with exposures to the chemical under
study?
2) Dose-Response Assessment: How is the probability of
the occurrence of adverse health effects related to the
magnitude and duration of exposure to the chemical?
3) Exposure Assessment: What is the extent of human ex¬
posure (past, present and future) to the chemical?
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4)   Risk Characterization:  What are the risks to public
health (a function of hazard and exposure) associated
with the chemical?  What are the uncertainties in
assessing this risk?
Uncertainties are present in each of these procedures which
require a decision or assumption to be made in order to proceed
with the assessment.  The points at which these decisions are
made are referred to as components.  The questions involved in
reaching a decision at a component are science policy questions,
so called because both science and policy considerations play a
role in their resolution:
The choices encountered in risk assessment rest, tovarying degrees, on a mixture of scientific fact andconcensus, on informed scientific judgments, and onpolicy determinations (the appropriate degree of con¬servatism).  (National Research Council, 1983)
More specifically, this type of science policy is known as
risk assessment policy, defined by the NRC as "policy related to
and subservient to the scientific content of the process, in
contrast with policy invoked to guide risk management decisions,
which has political, social, and economic determinants."
The lack of a consistent, rational risk assessment policy
for dealing with uncertainty in assessing risks of ChE-inhibiting
pesticides has resulted in the use of different criteria to
define "no observed effect levels" (NOELs) (both by researchers
performing dose-response studies and by EPA reviewers of those
studies), different uncertainty factors (UFs) being selected by
different EPA offices, and conflicing estimates of acceptable
daily intakes (ADIs) for the same pesticide. Although an intra-
Agency group has decided on which ADI to use in the cases where
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conflicting ADis have been proposed for the same pesticide, there
are many components in the risk assessment process which have
been inconsistently evaluated for different pesticides. This
problem has been recognized by various EPA scientists in regard
to ChE-inhibiting pesticides but has not been resolved. (EPA
internal memo, 1986).
It should be emphasized that the present state of affairs
regarding the inconsistent treatment of uncertainties in the risk
assessment of ChE-inhibiting pesticides is not due to either a) a
failure to maintain a clear conceptual distinction between
assessment of risks and consideration of risk management alterna¬
tives, as recommended by the NRC (1983), or b) faulty judgment on
the part of Agency scientists. Excellent scientists can reason¬
ably and rationally disagree over the human health implications
associated with varying degrees of cholinesterase inhibition due
to Ch-I pesticides.  However, as the NRC (1983) points outs
In establishing regulatory priorities, the same infer¬ence options should be chosen for all chemicals,because the main point of the analysis is to makeuseful risk comparisons so that agency resources willbe used rationally.  (NRC, 1983)
In addition, differential treatment of uncertainties is
unfair to industry as well as the public potentially at risk.
For example, the judgments and assumptions (all valid) made by a
more conservative EPA risk assessor could ultimately lead to
greater costs to the industry than if a different, less conserva¬
tive scientist prepared the assessment (Fisher, 1980).
The objective of this review is to improve the risk assess¬
ment process for ChE-l pesticides by identifying and discussing
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important components, particularly in the first two stages of the
assessment, which can influence the outcome of the process. The
results of this review could be a first step towards the develop¬
ment of a consistent and rational risk assessment policy for ChE-
I pesticides. The NRC four stage model of the risk assessment
procedure will be used to structure the analysis. Most examples
were obtained from human and animal data on cholinesterase inhi¬
bition by malathion, parathion, and aldicarb. These particu¬
lar pesticides were chosen because:
(a) they represent three main classes of ChE-I pesticides
(phosphorodithioates, phosphorothionates, and carba¬
mates,   respectively)
(b) they have high risk potential due to their toxicity
and/or extensive use
(c) there is ample health-related data, including studies
in humans
(d) they have  received public  attention.
ChE-I was chosen as the health endpoint in this review since it
is an early predictor of exposure and is often selected as the
basis  for characterizing  risks.     Data have been obtained  from:
a) EPA risk assessment documents (e.g. registration
standards,   criteria documents)
b) EPA reviews of original studies (e.g., "Caswell file"
reviews by scientists from the Office of Pesticide
Programs  (OPP))
c) open literature.
The major components to be analyzed in this review include
the following:
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EAZSJL^  Identification
o What degree of cholinesterase inhibition (ChE-I) is
significant (i.e., regarded as an effect)?
Dose-Response Assessment
o What dose-response assessment methods should be used to
extrapolate from experimental doses to exposure doses?
o What uncertainty factor should be employed for inter¬
species variation of ChE-I between animals and humans?
o What uncertainty factor should be employed for intra-
species variation of ChE-I?
Exposure Assessment
o   what special considerations should be included in expo¬
sure assessments for ChE-I pesticides?
Risk Characterization
o   What are the uncertainties in estimating the extent of
health effects for these compounds?  How should they be
estimated and presented to Agency decision makers?
Some of the uncertainties contributing to these components are
included in Appendix V-1.
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II.  Hazard Identification
A.   Cholinesterase Inhibition
Types of ChE
In mammals there are two types of enzymes which can react
with ChE-l pesticides: acetylcholinesterase (AChE) (also called
specific, "true" or "e" type cholinesterase, and acetylcholine
acetyl hydrolase) and butyrylcholinesterase (BuChE) (also called
nonspecific or pseudocholinesterase, "s" type cholinesterase, and
acylcholine acyl hydrolase). These can be distinguished by loca¬
tion and substrate specificity. AChE is found in the central
nervous system, motor end plates of skeletal muscle, and erythro¬
cytes, whereas BuChE is found in smooth muscle, liver, adipocytes
and plasma. BuChE has been found in almost all major body
systems including the white matter of the brain, vascular system,
respiratory system, digestive system, urogenital system, and also
in certain endocrine and exocrine glands. AChE hydrolyzes
acetylcholine (ACh) and acetyl beta methylcholine but very little
benzylcholine, propionylcholine, or butyrlcholine, which BuChE
readily hydrolyzes. BuChE can also hydrolyze ACh, but differs
from AChE in that it is inhibited by ACh at concentrations
greater than 100 micromoles (mM), whereas AChE is inhibited by
ACh concentrations greater than 4 mM (in vitro). ChE-I pesti¬
cides differ in their ability to selectively inhibit these
enzymes (i.e., some may inhibit only (or mainly) AChE, and
others only BuChE).
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AChE
Like all esterases, cholinesterases are hydrolases which
split ester (specifically choline ester) bonds. AChE plays a key
role in normal nervous system functioning by splitting the neuro¬
transmitter acetylcholine (ACh). ACh, stored in synaptic
vesicles, is released from the presynaptic cell into the synaptic
cleft once an action potential reaches the nerve terminal. It
then diffuses across the synaptic cleft and interacts with speci¬
fic receptor sites in the postsynaptic membrane. This interac¬
tion triggers changes in ion conduction which lead to, for
example, firing of a second neuron or a muscle contraction. ACh
can have an inhibitory effect (e.g., slowing the heart rate) or
excitatory effect (e.g., producing a skeletal muscle contrac¬
tion). ACh interacts with muscarinic receptors (found primarily
in smooth muscles, heart, and exocrine glands), nicotinic
receptors (at autonomic ganglia and neuromuscular junctions) and
receptors in the CNS. AChE is present in the synapse and
destroys ACh  very soon after  it is  released:
p 0 0 0
<-
K 'Ik 1' k '"EOH+  RC   -   0  -   R'<:ik^   EOH   (RC-0R')-4>   EOC-   R  -^>EOH  +   RCO" H
enzyme reversible  ^c**^    ^'^^  acyl(AChE)   ACh complex enzyme
intermediate
When a ChE-I pesticide is present, it reacts with ChE,
.preventing ACh from reacting with ChE. The only difference
between a ChE-I pesticide (an inhibitor) and ACh (a substrate) in
the reaction is the rate of the reaction (principally due to k3).
The acylated enzyme formed from ACh hydrolyzes very quickly,
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whereas the phosphorylated or carbamylated enzyme formed from an
organophosphate or carbamate hydrolyzes very slowly. This reac¬
tion (the restoration of the enzyme from its acylated (inhibited)
state) is knowji as spontaneous reactivation or deacylation, or
dephosphorylation in the case of OPs, and decarbamylation in the
case of carbamates.
In the case of OPs the k3 step of dephosphorylation is so
slow that these compounds are sometimes called "irreversible"
inhibitors of ChE. With carbamates, k3 is significantly slower
than it is for ACh but faster than for OPs, while ^2 ^^ slower
than for OPs, so that once the carbamate is removed, the enzyme
recovers (due to reversal of the reversible complex and decarba¬
mylation (by k3)). Hence, carbamates are considered "reversible"
inhibitors of ChE. Acute toxicity and death from OPs and carba¬
mates are thus really due to ACh poisoning as ACh accumulates.
Symptoms of acute poisoning mimic the muscarinic, nicotinic, and
CNS actions of ACh (Table II-l).
Phosphorylated ChE can be reactivated, not easily by water
as with acetylated ChE, but by nucleophilic compounds which can
displace the phosphate from the enzyme, such as pralidoxine (2-
PAM), used as an antidote. This antidote is not effective for OP
compounds which undergo "aging," or loss of one of the R-group
side chains: -C"
ͣ .      v,^^^ EOH + RO-f-OHEOH + RO^X ;=i EOH(ROf-X) ^^ EOP-OR + HX      .(enzyme)  OR' '< ͣ^     OR'      OR-    f \, ^q_^_q-^ p^^o^ „, P.ma
The negative charge on the aged phosphorylated AChE repels
2-PAM so that reactivation cannot occur. Some nerve gases age
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rapidly, precluding the effective use of these antidotes. Atro¬
pine, another antidote for ChE-I pesticides, works by competi¬
tively inhibiting ACh at the receptor.
The role of AChE found in the synapses of nervous tissue is
actually much more complicated than the preceding description
implies, since AChE exists in a number of different varieties or
molecular forms, each of which is thought to serve a different
role, and might possibly be regulated separately (Brimijoin,
1983). However, it is typically the AChE found in erythrocytes
that is measured to determine OP and carbamate toxicity, since it
is impractical to measure synaptic AChE activity. The function
of RBC AChE is not as well established as that of synaptic AChE,
RBC AChE may protect synaptic AChE by reacting with some of an
absorbed dose of AChE-I pesticide before it reaches the synapses,
although this would vary between different ChE-I pesticides.
Wills (1972) maintains that "there is no good evidence that that
enzyme [RBC AChE] does anything more than control to a certain
extent the permeability of the erythrocyte." Non-synaptic AChE
is thought by some to maintain excitability and to initiate and
propagate action potentials in nerve and muscle through regula¬
tion of electrolyte transport (Namba, 1971), although this has
been disputed (Herz and Kaplan, 1973). From observations that
RBC AChE levels increase after blood loss and are altered in
several different types of anemia, it was inferred that RBC AChE
activity is related to cell age, high levels being associated
with rapid production of erythrocytes (Herz and Kaplan, 1973),
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This   is   a   potential   source   of   variability  in   using  measurements
of AChE  as   indicators  of exposure  to ChE-I pesticides.
Not only are AChE levels high during the formation of RBCs,
but Drews (1975) observed elevated ChE levels in the blastemal
cells of developing organs in several species. Once the organ
structure became established, ChE activity disappeared. CliE
activity was always found in cells which, in the course of organ
formation, moved actively. Drews hypothesized that ACh'is
involved in the short range regulation of movements in developing
organs. Specificity tests were run on the embryonic ChE to
determine its type, which was discovered to be AChE in the
amphibian and chick embryo, as well as in human carcinoma, and
nonspecific or BuChE in the rat embryo and juvenile rat mammary
gland and uterine epithelium. Because ChE plays a role in
embryonic development which is different from its known function
in the adult, it is called "embryonic ChE." The presence of
embryonic ChE may partially explain why the fetus is more sensi¬
tive to ChE-I pesticides than the adult. Differences in sensi¬
tivity due to age are discussed  later  in this section.
Although BuChE has been detected in almost all major
mammalian body systems, its biological function has not been
established, and its natural substrates and inducers are unknown.
It is faily well established that it is produced in the liver.
Several hypotheses as to its function have been suggested (Kutty,1980): '
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a) May be  a  precursor  of AChE.
b) May be involved in myelin structure (BuChE has been
found in Schwann cells of nerves and between folds of
myelin   in  some central  axons).
c) May control choline levels in plasma (used to
synthesize ACh).
d) May act as a backup for AChE to destroy circulating
ACh.
e) May be involved in structure and/or synthesis of beta-
lipoproteins (is found coraplexed with beta-lipo-
protein) .
f) May removes toxic esters formed by fatty acid
metabolism.
g) May be involved in assimilation of food (serum BuChE
activity decreases after fasting, parallels level of
food intake in undernourished children, and is elevated
in obese and diabetic patients, and persons with hyper¬
lipoproteinemia   (abnormal   lipid metabolism)).
Thus, although BuChE and AChE share many similarities
(mechanism of action, molecular shape, etc.) it is not known how,
if at all, they are related physiologically [Edwards and
Brimijoin,   1982].
Hazard Identification Issues Re;ChE-i
Although there are still many questions to be answered, it
should be remembered that AChE has been characterized as "one of
the best studied of all enzymes" [Brimijoin, 1983]. Despite
uncertainties   regarding   the  roles of AChE  in  erythrocytes and
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BuChE in plasma, substantial inhibition of these enzymes is
associated with overt adverse effects in the whole organism
following administration of OPs and carbamates and is currently
used as a measure of toxicity as well as a measure of exposure to
these  pesticides   (Table   II-2).
If we assume ChE-I in RBCs and plasma to represent an
adverse  effect,   the  following  questions  should be considered:
a) How do AChE and BuChE levels respond to prolonged
exposures to ChE-I pesticides (i.e., how does ChE-I
relate to length of study?) What is the significance
of such prolonged  exposures?
b) What is the effect of age, sex, diet, race, health and
other genetic and environmental factors on ChE levels?
How does this affect susceptibitily to ChE-I pesti¬
cides?
c) How accurate and reliable are available methodologies
for measuring ChE-I?    How do they differ?
Each of these  issues will be considered  in turn.
Chronic  Exposure  to ChE-I  Pesticides
The   preceding   description   of  ChE-I   reflects   the   immediate
biochemical events following exposure to a ChE-I pesticide.     What
happens when the exposure  is continuous,   for months or years?
It is known that animals repeatedly exposed to certain ChE-I
pesticides develop tolerance to the (acute) toxicity of these
pesticides (i.e., signs of acute poisoning disappear with con¬
tinued administration). According to Chambers and Yarbrough
(1982)   this   is  due   in  some cases   (e.g.   disulfoton)   to  a  decreased
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number of muscarinic receptors in target tissues that are capable
of binding the ACh which accumulates when AChE is being
inhibited, and in some other cases (e.g. propoxur) due to en¬
hanced enzymatic detoxication.
In spite of this, ChE levels may remain inhibited or
decrease even more in long-term exposures. Figures III-l - III-4
show the inhibition of ChE's in plasma and erythrocytes by
parathion in dogs over two, four, and twelve months. In this
experiment the percentage decrease (from control values) is the
greatest at 12 months at every dose (except for RBC ChE of female
dogs). In other words ChE was inhibited more after one year than
after two or four months. Table II-3 compares ChE-I NOELs for
the same species, pesticide, route of administration, and site of
ChE (i.e., plasma or red blood cell (RBC) but differing study
lengths, for seven pesticides (see Appendix III-3). In the
majority of cases the NOELs are lower in longer (chronic) studies
than in shorter (subchronic) studies. Possible differences in
study designs (e.g., method used to determine ChE-I, comparisons
to unexposed animals vs. pre-exposed animals, strain) and the
small number of comparisons made (16) prevents any definitive
conclusion, but the results suggest that ChE-I NOELs vary by
duration of exposures such that chronic ChE-I NOELs are lower
than subchronic NOELs. According to Bartholomew et al. (1985), a
decrease (or absence) of acute toxic effects occurs despite
continued inhibition of brain ChE activity and elevation of ACh
concentrations.
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Wills (1972) maintains that "In general, prolonged or re¬
peated exposures to inhibitors of cholinesterases have emphasized
the unreliability of estimations of the activities of plasma, or
serum, and red blood cells for judging the severity of intoxica¬
tion by these inhibitors." Levels of ChE-I fluctuate over the
course of chronic and subchronic exposure. For exaitiple. Wills
cites an example in which pigs fed 1.7 mg/kg/day of parathion had
increased levels of plasma ChE at first, and then decreased
levels until maximum inhibition (43%) occurred on about the 50th
day. RBC AChE levels remained unaffected for 8 days of dosing,
and then fell gradually until maximum inhibition (86%) occurred,
also on day 50. Studies in which ChE activity is infrequently
measured may not be able to determine maximum inhibition. In
addition, there is some indication that the x^is. of ChE-I may
affect toxicity (Wills, 1972). Jensen (1965) found that the
lethal dose of paraoxon in guinea pigs increases at an increased
rate   of   infusion.
Although tolerance appears to develop to the acute toxicity
associated with ChE-I, what are the chronic toxic effects asso¬
ciated with ChE-I? (Recall that both acute and chronic effects
may result from either acute or chronic exposures). Investiga¬
tions to date have yielded conflicting claims regarding the
existence of chronic neurobehavioral effects (Duffy et al., 1979;
Ecobichon and Joy, 1982; Karczmar, 1984; Levin, 1976; Miller,
1982; National Research Council, 1985, Savage et al., 1982).
These and other chronic effects (carcinogenic, nephrotic) linked
to some ChE-I pesticides or their metabolites will not be con¬
sidered   here.
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•fnl-r;^species  Variation   of  ChE
Not only is ChE activity affected by exposure to ChE-I
pesticides, but it also varies among species (see section HID),
and is affected by age, sex, diet, genetic status, race, pregnan¬
cy, obesity, season, liver disease, myocardial infarction, and
other health and environmental factors. Plasma ChE levels
fluctuate more than RBC AChE levels,
o Genetic Factors •
A small sub-group of the population (estimated by Williams
(1985) to be 4.5%) possess genetically determined atypical plasma
ChE. Atypical ChE was first discovered when the muscle relaxant
succinylchol ine, used in anaesthesia, was found to produce an
unusually long period of paralysis and apnea (temporary suspen¬
sion of breathing) in some patients. These individuals were
found to have atypical or low serum ChE, which is responsible for
the hydrolysis of succinylcholine, thus ending the drug's
effects. Genetic studies since then have shown that most people
with atypical BuChE are homozygous for a recessive gene
(designated E^a Ej^). The gene allele E^^^ directs the synthesis
of a ChE which is unable to hydrolyze succinylcholine at pharma¬
cological doses and which is also less sensitive to certain ChE-
I's (e.g., dibucaine). The latter property is used to classify
serum ChEs, by use of the dibucaine number (DN), a measure of the
degree of inhibition (expressed as a percentage) of serum cho-
linesterase obtained with dibucaine under standardized conditions
(Kalow, 1957). Whereas most people (with normal genotype E^*^
Ej")   have  a DN between  76  and   81,   those who  are  heterozygotes
(Ej" E^^)  have a DN between 55 and 69,  have about seventy-eight
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percent as much ChE as normal, and may display a mild increase
in sensitivity to succinylcholine, and those who are homozygous
for the recessive gene (E-j^^ E^^) have a DN below 21 and have low
BuChE activity (about twenty-five percent of normal) and sensi¬
tivity to succinylcholine [Ashby et al. (1970), Udsin (1970)].
Other genetic variants of plasma ChE have been identified,
including a fluoride-resistant form (directed by E^^ allele), a
completely ineffective or absent "form" (directed by the
"silent" allele E^^), and the J and K phenotypes (associated with
reductions in measured enzyme activity of ca. 66% and 33%,
respectively). The J and K phenotypes can only be identified
with certainty when they occur with the atypical variant (i.e.,
^1^ ^1^ ^^^ ^1^ ^1^ have distinctive inhibitor numbers). A
variety of combinations are possible (e.g., Ej^" ^1 ' ^1^ ^1 '
Ej^u E^s, E^f E^^, E-^^ EjL^, E-^^ Ej^^, Ej^^ E^^, E-^^ E^^, E^'^ E^^"^)
(Evans and Wardell, 1984).
Genetic variants with an atypical number of electrophoreti-
cal ly-detectable isoenzymes have also been detected (Silver,
1974). Although most individuals possess bands C^, C2, C3 and
C4, a fifth band (C5) was identified in fourteen of three
hundred randomly selected adults in England, and has been de¬
tected in other populations as well (e.g., Brazilian). Three
additional bands are present in serum from certain Africans. The
level of serum ChE is about 30% higher in subjects with C5 than
in C^-negative subjects.  (Silver, 1974).
Apart from increased sensitivity to succinylcholine, there
are no reports of clinical abnormalities in people with rare
genetic variants of serum ChE.  Silver (1974) reports that in one
11-11
»   r
instance where other tissues (including brain) were investigated
in a person with atypical serum enzyme, the tissue enzyme was
similarly atypical. It is not apparent whether these people
would be msULS. susceptible to ChE-I pesticides, since their serum
ChE is unable to hydrolyze accumulating cholines; Isss
susceptible, since their serum ChE is less sensitive to certain
ChE-I's (e.g. dibucaine, fluoride); or equally susceptible.
Calabrese (1978) maintains that individuals with such pseudo-
cholinesterase variants should be considered potentially at high
risk to ChE-I pesticides. Calabrese also notes that the dibu¬
caine variant has been found to be extremely sensitive to R02-
0683, and cautions that this is of "particular significance in
light of the widespread use of carbamate insecticides." However,
the OP's TEPP and DEP isofluorophosphate do not inhibit differen¬
tially among pseudocholinesterase variants and would not cause a
higher   risk  to  those individuals with atypical  variants.
Another indication that genetic factors may affect suscepti¬
bility to ChE-I pesticides is provided through selective breeding
experiments in animals by Overstreet et al. (1979). Male rats
determined to be most resistant and most sensitive to DPP on the
basis of drinking behavior, body weight, and core body tem¬
perature were bred with the most resistant and sensitive (respec¬
tively) female rats in an attempt to establish resistant and
sensitive lineages. Although the former attempt failed,
Overstreet et al. were successful in establishing a sensitive
line of rats. However, the genetic differences in sensitivity
were not  found   to be   related   to  differences   in  brain  or   erythro-
II  - 12
cyte AChE or serum BuChE activity. The authors speculate that
the genetic differences could be due to changes in sensitivity of
AChE isoenzyme, changes in ACh synthesis or turnover, or changes
in sensitivity of postsynaptic receptors for ACh. Subsequent
studies (Overstreet et al., 1984) have shown that the latter two
factors do indeed contribute to the enhanced sensitivity
observed. Regardless, the data suggests that ChE-I may not
always be an adequate measure of toxicity in genetically-
susceptible individuals.
Besides genetic differences in ChEs, there is another
esterase that is affected by organophosphates and carbamates,
known as arylesterase, for which genetic variants exist.
Arylesterases have not been as well studied as other esterases.
Paraoxonase, an enzyme hydrolyzing paraoxon, the active
metabolite of parathion, is an arylesterase which has been found
to be polymorphically distributed in several populations (LaDu
and Eckerson, 1984). Two alleles determine paraoxonase activity:
A, a low activity allele, and B, a high activity allele. Hetero-
zygotes (AB) also exhibit high activity. About one-half of the
U.S. Caucasian population is homozygous for the low activity
allele (AA), which is speculated to place these individuals at
higher risk of parathion poisoning than those with higher levels
(Ortigoza-Ferado et al., 1984). Non-caucasian populations of
African, Oriental, or American Indian subjects, for example, do
not show the same distribution, but it is not known whether this
is due to the presence of additional alleles or quite different
gene frequencies (LaDu and Eckerson, 1984). Ortigoza-Ferado et
al.   state  "It  may be  postulated   that  such  differential   suscepti-
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bility would be particularly significant at low or intermediate
levels of exposure to parathion since with marked exposure even
high levels of paraoxonase would not be sufficient for protection
against toxicity."
It appears, then, that both ChE and arylesterases (e.g.,
paraoxonase) affect the toxicity of ChE-I pesticides. A model
describing the interaction of paraoxon with serum ChE and para¬
oxonase was developed by LaDu and Eckerson (1984). The level of
paraoxonase was found to influence the degree of serum ChE-I in
vitro. The authors recommend that the in vitro model system be
applied to estimate what is likely to occur in vivo, and that
epidemiological studies be undertaken to determine whether indi¬
vidual response to ChE-I pesticides shows the expected relation¬
ship to the type and level of paraoxonase.
o   Sex Differences
Sex related differences in susceptibility to ChE-I pesti¬
cides are most likely to occur for those compounds which require
metabolic activation to produce ChE-I (e.g., parathion). (Doull,
1980). Agarwal et al. (1982) found that the percentage of ChE-I
by parathion was 2.6, 1.2, and 2.7 times greater in female than
male rats measured in plasma, erythrocytes, and brain, respec¬
tively, following a single oral dose. Paraoxon treatment, how¬
ever, resulted in comparable inhibition of plasma, erythrocyte
and brain ChE in both sexes. Castration increased the suscepti¬
bility of male rats to a similar level as females. Pre-treatment
with testosterone enabled these castrated males to recover from
this increased sensitivity, whereas estradiol enhanced their
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sensitivity slightly. Gonadectomy had little effect on ChE
levels in the females. Pre-treatment with testosterone decreased
the sensitivity of ovariectomized females. The authors concluded
that testosterone plays an important role in determining
parathion   toxicity.
While it is well established that the female rat is more
susceptible to the acute toxic effects of parathion (e.g., LD^q
and ChE-I) than male rats, this sex difference is not as obvious
for chronic or subchronic ChE-I. For example, in a 2 year feed¬
ing study in rats prepared by Daly (1984) for Monsanto (in Ghali,
1985),   no  consistent  pattern   is  observed.
Sex differences exist in absorption, distribution, and
excretion of ChE-I pesticides also. For example, Khaak et al.
(1984) found that less parathion was lost by evaporation from the
skin of male than female rats, males having a larger percentage
of the dose in their carcasses. Similar amounts in both sexes
were excreted in the urine and feces. Although the amount
absorbed from the skin was about the same over a 120 hour period
in male and female rats, males absorbed parathion from the skin
much more rapidly. Females absorbed more in heart and liver
tissue than males.
The plasma and red blood cells of human males have higher
ChE activities than human females   (Wills,   1972).     Serum ChE is
significantly decreased   in  women   using   oral   contraceptive  pills
(Robertson,   1967).     How  this   affects   susceptibility   in   humans   is
not clear, although in the rat,  the female is more susceptible
and  has higher ChE activities than  the male,
o Age
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Kacew and Reasor (1984) report that "it is clear that neo¬
nates are more susceptible than adults to AChE inhibitors."
Although the hepatic cytochrome P450 system which catalyzes some
OPs to their active metabolites (e.g., parathion to paraoxon) is
poorly developed in neonates, neonates are still more sensitive,
apparently due to differences in detoxification, excretion, or
redistribution. For example, the level of the enzyme that
degrades malaoxon (carboxylic ester hydrolase) is less than the
level of the activating enzyme for the first thirty days of life
of the rat. By thirty days of age malaoxon inactivation is equal
to its rate of production (Kacew and Reasor, 1984).
Besides such differences in detoxification ability, the
specific activity of brain AChE increases from a minimum in the
one day old rat, either due to an increase in the amount of AChE
or its catalytic activity (Kacew and Reasor, 1984).
In the human, adult levels of AChE are not reached until
three to five months of age. Even though blood from neonates has
a higher proportion of young cells (which have higher activity
than more mature cells) than adults, AChE activity in newborn
circulating erythrocytes is less (Herz and Kaplan, 1973). Thus,
for a given concentration of ChE-I pesticide, more AChE is
expected to be inhibited in newborns compared to adults (Kacew
and Reasor, 1984). This has been found to be the case with beef
cattle given ChE-I pesticides to control parasites, according to
Kacew and Reasor. Chlorpyrifos is thirty-fold more toxic to
calves than adult cattle. Brodeur and Dubois (1963) compared the
I'D5o's of sixteen ChE-I pesticides given intraperitoneal ly for
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twenty-three day old weanling and adult rats. The acute toxicity
was from one to five times greater for weanlings than adults,
except for OMPA, for which adults were five fold more sensitive.
On average, weanlings were twice as sensitive as adults. Mendoza
and Shields (1977) compared the LD5q's of rat pups treated with
malathion (99.3%) by gastric intubation and found that one-day
old pups were three times more sensitive than six day old pups
and nine times more sensitive than eighteen day old pups.
Similarly, the I50 (concentration of malathion required to
inhibit ChE by fifty percent at specified conditions) of one day
old pups measured for brain AChE was one-third, one-fourth, and
one-eighth the amount in six day, twelve day, and eighteen day
old pups, respectively. Lu, Jessup and LaVallee (1965) compared
oral LDjq's for malathion (99.6%) in rats of different ages and
observed that newborns were twenty-eight times more sensitve than
adults and seven times more sensitive than pre-weaning rats.
They also observed that dividing the dose over four days reduced
the toxicity in adults but increased the toxicity in pre-weaning
rats.
Parathion, malathion and aldicarb all pass through the
placenta and are toxic to the fetus. Malathion and parathion
have been shown to have teratogenic effects [Calabrese (1978),
Fish (1966), Hoffman and Eastin (1981), Wyttenbach and Thompson
(1985), etc.]. Cambon et al. (1979a) found that AChE in the
brain and blood (but not liver) of rat fetuses was consistently
more inhibited than that of the dams treated by gastric intuba¬
tion with aldicarb on the eighteenth day of gestation. Carbo-
furan consistently inhibited brain AChE more in the dam than in
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the fetus, while for pirimicarb, no consistent pattern was
observed. Cambon et al. (1976b) hypothesize that the reason for
the observed differences in sensitivity are due to differences in
fixation of carbamate derivatives on the fetal versus maternal
isoenzymes.
The sensitivity of the elderly to ChE-I pesticides is less
clear than for the very young and unborn. Rider et al. (1957)
found that plasma ChE showed a small but definite increase with
age in both sexes. Other investigators [Calloway et al (1951),
Gage (1969)] did not find age to be a factor influencing the
magnitude of variability of ChE in adults. Ando et al. (1984)
found that serum ChE activity increased according to age in
females, while it decreased slightly according to age in males.
The ChE activity was higher in males than in females under fifty
years of age, whereas the reverse was found in persons over
fifty-five years of age. They also detected seasonal variation
(higher activity in winter than summer) in females but not males.
There does not appear to be any conclusive evidence indicating
that adults of any specific age may be more sensitive to ChE-I
pesticides.
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o   Nutrition
Nutritional deficiencies have been found in some cases to
increase the susceptibility of test animals to ChE-I pesticides.
Parathion, malathion and banol all produced greater ChE-I in rats
on low protein diets than on high protein diets (Casterline at
al. (1969a, b, 1971 a, b) , Vaishwanar and Mallik (1984)). Para-
thion-induced serum ChE-I was more dependent on dietary protein
levels for subchronically-exposed rats (28 days) than for acutely
exposed animals (single dose) (Casterline and Williams, 1971).
Behavioral changes were noted more often in rats on low protein
diets exposed to parathion or banol than in unexposed rats on low
protein diets or exposed rats on high protein diets (Casterline,
Brodie and Sobotka, 1971). These behavioral changes consisted of
a higher proportion of "No escape" rats (i.e., rats failing to
press a lever to either avoid or escape a negative stimulus
[electric shock] after training in a standard operant condition¬
ing chamber). None of the diet-pesticide groups tested were
associated with significant changes in avoidance only behavior
(lever pressing during conditioned stimuli [light and sound]
preceding the unconditioned stimulus [shock from electric
grids]). In this experiment, although behavioral changes were
noted, the activites of ChE (and monoamine oxidase (MAO)) in the
cerebellum and cerebrum were not significantly affected by the
low casein diet and/or the presence of a ChE-I pesticide. Since
brain ChE can not be assayed until the end of the experiment (at
9 weeks in the parathion experiment and 10 weeks in the banol
experiment), it is possible that inhibition may have occurred
earlier in the experiment, preceding  adaptation to chronic
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exposure. In fact, brain ChE-I was noted in a similar 28 day
experiment by the same investigator (Casterline and Williams,
1971). It is noteworthy that behavioral effects can be observed
following subchronic exposure to a ChE-I pesticide even when
brain AChE levels are not inhibited. Subchronic exposure to
parathion was found to decrease serum and liver triacetinesterase
(AliE) activities in protein-deprived animals as well as ChE
activities, thus reducing the detoxification ability in those
animals and making them highly susceptible to poisoning, even at
low doses   (Casterline and Williams,   1971).
In addition to protein (casein), varying dietary levels of
calcium (Ca) and magnesium (Mg) also affected ChE-I by parathion
and banol (Casterline and Williams, 1969a). Both high and low
levels of these cations decreased serum and brain ChE-I by para¬
thion and banol. Liver ChE-I was also decreased by parathion and
banol, except by low magnesium which increased ChE-I by para¬
thion. Serum and brain AliE by parathion and banol was un¬
affected or decreased by altered cation levels, while liver AliE-
I by parathion and banol was significantly increased by high Mg
or high Ca in the diet. These results are difficult to inter¬
pret, since they imply that low or high dietary concentrations of
Mg or Ca might decrease susceptibility to parathion and banol
since ChE-I by these compounds is reduced. However, the changes
in ChE and AliE that occurred after pesticide administration did
not influence the lethal action of the pesticides, except with
the  casein-free diet,   where  the mortality was   increased.
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Animals on food restricted diets, or deprived of water, were
also shown to be more susceptible to subchronic (via diet) and
acute exposures (via intraperitoneal injection) of parathion and
paraoxon (Baetjer, 1983 and Villeneuve et al., 1978). Food
restriction had a significantly greater effect than water depri¬
vation on blood ChE-I by parathion, but not paraoxon.
In the subchronic study, food restriction increased plasma
ChE-I elicited by parathion, but brain ChE was not inhibited by
the doses of parathion used, either alone or with food restric¬
tion. Increased inhibition of plasma ChE in animals subjected to
food restriction was not observed at the NOEL for the study.
o   Pregnancy
During routine blood ChE monitoring at a pesticide industry,
it was observed that a marked fall in plasma ChE occurred in
pregnant women in their first trimester who had not been exposed
to ChE-I pesticides (Howard et al., 1978). A more extensive
survey by Evans and Wroe (1980) on 941 pregnant women distributed
evenly throughout the 40 weeks of gestation revealed that a rapid
fall occurred in the first trimester to a level which did not
alter significantly during the remainder of pregnancy. Even
lower values were observed in the 105 patients examined during
the week following delivery. Three of the women surveyed
possessed abnormal genotypes (i.e., E^^^ ^i^^ ^i^ ^1^' ^"^
E^ ^i ) and were excluded from the study. Nevertheless, some
women were determined to be at risk to succinylchol ine on the
basis of ChE activity between 1.68 and 2 units/ml. The numbers
of pregnant women at risk for each time period investigated
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closely paralleled the changes in mean enzyme activity over time,
with the highest risk of apnea and prolonged effects of succinyl-
choline occurring  immediately after delivery.
How do low levels of plasma ChE occurring during pregnancy
affect susceptibility to ChE-I pesticides? Recall that it was
unclear whether individuals possessing non-normal genotypes and
low levels of plasma ChE would be more susceptible to ChE-I
pesticides due to the decreased ability of plasma ChE to hydro-
lyze cholines, or less susceptible since their plasma ChE was
found to be less sensitive to fluoride, dibucaine, and some other
ChE-I compounds. Weitman et al. (1983) found pregnant mice to be
more susceptible to single doses of parathion and paraoxon than
virgin female controls. In pregnant mice, signs of cholinergic
stimulation (tremor, weakness, lacrimation, salivation) were more
intense, brain and plasma ChE activites were lower, blood and
brain concentrations of parathion and paraoxon were higher, and
serum paraoxonase activities were lower, compared to controls.
Whether pregnancy-induced alterations of hepatic function, ChE
activity, serum protein binding, serum esterases or a combination
of these are responsible for the enhanced susceptibility is
unclear,
o Miscellaneous Health and Environmental Factors
The susceptibility to ChE-I pesticides can be affected by
exposures to physical factors (e.g., cold), biological agents
(e.g., viruses), and other toxic substances (e.g., pesticides,
drugs) .
Not only can the toxicity of ChE-I pesticides be altered in
individuals  with  hypo- or  hyperthermia,   but ChE-I  pesticides  may
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have hypothermic effects. Doull (1980) reports that hyperthermia
increases the toxicity of parathion, while Chattopadhyay (1982)
found that half the LD50 dose of parathion was lethal under cold
temperature.
The percent whole blood ChE-I by DDVP was significantly less
in cold-exposed rats than in rats at room temperature, but by
parathion was significantly more at one-half the LD^q dose and
unaltered at one-quarter of the LD5Q dose. Chattopadhyay (1982)
also noted hypothermic efects of OPs in rats under cold exposure.
Body temperature decreased as the dose of OP increased, and the
higher the ChE-I the lower was the body temperature of the
animals  under  cold  temperature.
Whole-body radiation produces a dose-dependent decrease in
BuCh activity of the ilia in rats and mice, but there is no
significant change in the acute toxicity of ChE-I pesticides in
animals given lethal exposures of whole-body ionizing radiation
(Doull,   1980).
Doses of parathion ordinarily considered sublethal were
lethal to mice infected with the virus MCMV (murine cytomegalo¬
virus),, apparently due to a decrease in the ability of infected
mice to detoxify parathion (Belgrade et al., 1984). MCMV is well
established as a model for human cytomegalovirus, a ubiquitous
herpes virus which infects a large portion of the population and
remains with the host  in  a   latent  state  for  a   lifetime.
The effects of human cytomegalovirus are usually subclinical
or indistinct, but infections can be manifested congenital ly,
perinatally,   in  individuals who are  immunosuppressed,   and  in some
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other instances. Serum ChE was inhibited more by infected mice
compared   to  uninfected  mice.
Synergistic interactions among ChE-I pesticides are known to
occur. Most of the studies of synergism among these compounds
have tested for acute toxicity. According to Doull (1980),
combinations of several OP pesticides fed at "recommended toler¬
ance levels" failed to produce significant synergistic toxicity
in  chronic   feeding   studies.
Malathion is potentiated by many OPs since it is detoxified
by carboxylesterases that are inhibited by other OPs. Potentia¬
tion of malathion is known to vary across species. For example,
TOTP (triorthotoly1 phosphate) given at a dose which alone did
not significantly affect brain AChE potentiated the anti¬
cholinesterase action of malathion by 29-fold in mice, 17-fold in
quail, 100-fold in frog, 11-fold in sunfish and 12-fold in bull¬
heads (Cohen and Murphy, 1970). Isomalathion and other impuri¬
ties in technical malathion potentiate malathion and are believed
responsible for an epidemic poisoning in Pakistan in 1976 during
a malaria eradication program (Aldridge et al., 1979). Potentia¬
tion of malathion by these impurities is significantly less in
the mouse  compared with  the   rat   (Umetsu  et  al.,   1977).
Potentiation can also occur between drugs and ChE-I pesti¬
cides. For example, chlorpromazine, a tranquilizer, has been
shown to potentiate dichlorvos toxicity in rats, producing about
twice as much ChE-I as dichlorvos alone. Drugs that deplete
glutathione (e.g., acetaminophen) may potentiate the toxicity of
some OPs which are detoxified by glutathione transferases
(Marquis,    1986).
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In contrast, organochlorine (OC) insecticides protect
against the acute toxicity of several OP insecticides. This is
probably because OC's stimulate detoxification of OPs by liver
microsomes and increase noncatalytic binding sites for OPs
(Doull, J980), Lead was observed not to potentiate parathion
toxicity (Phillips et al., 1973). However, both lead and cadmium
decreased AChE in rat brain following chronic exposure in,the
animals' drinking water (Marquis, 1986). Marquis (1986)
summarized her review of heavy metal interaction with pesticides:
"Clearly, the CNS is rendered more susceptible to the hazards of
ChE inhibition in animals chronically intoxicated by heavy
metals."
ChE levels are known to vary with certain disease conditions
(Silver, 1974). A decrease in serum ChE levels has been asso¬
ciated with some forms of anemia, liver disease, carcinoma,
epilepsy, eczema, rheumatic fever, typhus, tetanus, kwashiorkor,
and tuberculosis, while an increase in serum ChE levels has been
associated with diabetes, asthma, obesity, kidney disease, hyper¬
thyroidism and hyperlipoproteinemia (abnormal lipid metabolism).
Patients with mental abnormalities, including psychopathic
patients, had raised levels of serum ChE more often than control
subjects, A decrease in the ChE's of both serum and erythrocytes
has been noted in cases of renal ischaemia. Spastic children
have higher activities towards ACh in serum than either mongoloid
or moronic children, who have activities within normal limits.
ChE levels in erythrocytes are below normal in schizophrenics.
According to a study reported by Silver, the stress associated
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with sitting university examinations can cause an increase in ChE
levels in whole blood from healthy students. Alcohol and nico¬
tine have been shown to depress brain AChE levels. It is not
clear whether or to what extent individuals with these diverse
conditions may have altered susceptibility to ChE-I pesticides.
Individuals  with   low ChE  activities  may be at  high  risk.
Methodology
Several reviews of the methods for determining ChE activity
are available [Silver (1974), Wills (1972), Augustinsson (1971)].
These methods vary in their accuracy, complexity, efficiency, and
units measured. The conditions to which the enzyme is subjected
differ according to the method used, and thus the results ob¬
tained by different methods are not directly comparable (Silver,
1974). Temperature, pH, substrate, buffer, and contaminants
(e.g. salts, detergents) can affect the measurement of ChE acti¬
vity. Activities may be reported as the change in pH in a weak
buffer solution due to the release of acetic acid from ACh (e.g.,
Michel method); the amount of CO2 evolved from bicarbonate by
acetic acid released from ACh (e.g. Warburg manometric method);
the volume of sodium hydroxide needed to hold the pH of the
reaction mixture constant (e.g. Hall and Lucas continuous titra¬
tion or pH Stat method); or the amount of substrate (e.g., ACh,.
BzCh (benzoylcholine), BuCh) hydrolyzed. Reporting ChE activity
in terms of micromoles of substrate hydrolyzed per ml per minute
makes comparisons more valuable (Cornish, 1971). Analysis of ChE
following   inhibition  by carbamates   requires  special  methods.
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since the complexes formed with ChEs by all but a few of the
carbamates are readily dissociable by dilution (Wills, 1972).
As previously mentioned, it is important that ChE activity
be assayed frequently to detect peak inhibition during chronic
studies of ChE-l by pesticides. Different pesticides reach peak
ChE-l at different times in different species. Also, a lack of
ChE-I should not be considered as a true absence of effect when
ChE is measured at only one site (e.g., plasma). For example
Cornish (1971) cites a study with guthion in which brain ChE
activity was inhibited by 60% while serum ChE was unaffected.
Measuring only serum ChE would have resulted in a serious under¬
estimation of the risk posed by guthion. Brain and blood contain
both AChE and BuChE, so it is recommended that activities be
determined separately. Reporting activities in terms of percent
of mean control activity, while permitting comparisons between
levels, does not provide information on the pre-exposure condi¬
tion of the animal nor the variability involved. Even in studies
using laboratory animals, where one would expect little varia¬
tion, considerable variation may be present (e.g., see figures
III 1-4). Gage (1967) has pointed out the limitations of com¬
paring individual ChE activities to a population average since
the coefficients of variation in control studies range from 10 to
25 percent. A much better control is a series of pre-exposure
levels on the individual or animal to be studied. Reporting the
variability encountered in a study provides more flexibility in
the choice of dose-response assessment methods (see Section III
of this report).
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Table II-l:
Receptor
Effects of ChE-l Pesticides Linked to ACh
Accumulation at Various Receptor Sites
Muscarinic
(smooth muscles,
heart, exocrine
glands)
2.   Nicotinic
neuromuscular
junction
autonomic
ganglia
£ff£Ci
a) bronchoconstriction  and
increased bronchial
secretions, resulting in
wheezing and chest tightness.
b) increased salivation,     ,
lacrimation, and sweating
c) increased GI tone and
peristalsis, resulting in
nausea, vomiting, abdominal
cramps, diarrhea, tenesmus,
and involuntary defecation
d) bradycardia
e) smooth muscle contraction in
bladder, resulting in
involuntary urination
f) contraction of pupils
a) easy fatigue, weakness,
involuntary twitching, cramps,
fasiculation, and respiratory
muscular weakness leading to
dyspnea and cyanosis
b) pallor, elevated blood
pressure, hyperglycemia, and
other effects which can mask
II T-1
Receptor Effpct-
3.   Central nervous
system
muscarinic effects (e.g.,
tachycardia)
a) behavioral effects:  tension,
anxiety, restlessness,
insomnia, headache, emotional
instability and neurosis, ^
excessive dreaming and
nightmares, apathy, confusion
b) neurological effects:  slurred
speech, tremor, generalized
weakness, ataxia, convulsions,
depression of respiratory and
circulatory centers, coma
[Adapted from Doull, 1980]
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Table II-2: Incidence of Symptoms from Poisoning by ChE-l
Pesticides Associated with ChE-I in Red Blood
Cells *
Incidence of Symptoms
Strongly Correlated
(no.90) with Amount
of ChE-I
Incidence of Symptoms
Associated with ChE-I,
but not Strongly
Correlated with Amount
of ChE-I
Eye
Miosis
Lacrimation, Pain
Dimness of Vision
Impaired Accomodation
Pain on Accomodation
Injection Conjunctiva
Central Nervous System
Dreams, Poor Sleep
Increased Perspiration
Dizziness
Paresthesia and Cold
Gastrointestinal
Anorexia and Nausea
Nose
Rhinorrhea
Respiratory
Constriction of Chest
Cough
Wheezing and Rales
Dyspnea
Central Nervous System
Headache (r=.89)
Fatigability
Nervous and Irritable,
Mood Changes (r=.82)
Tremor and Twitch,
Fasiculation (r=.74)
Derived from 449 cases of anticholinesterase poisoning.
Amount of RBC ChE-I determined using an average of pre¬
exposure values as the control (adapted from Holmes and Gaon
(1956) .
II T-3
Table  II-3:  ChE-l NOEL (mg/kg/d) and Length of Feeding Study
Pesticide, Species Length of Study Trend
33-34 d.  56 d.  90 d.  6 mo.  1 yr.  2 yr.
Parathion, rat (SD)
plasma <.125 .025    (4.)?
Parathion, dog
plasma
RBC
(beagle)
<.3
.3(male)
<.01
<.01
(J.)?
Malathion, rat
plasma
RBC
50
5
5.0
5.0
4^
Chlorthiophos,
plasma
RBC
rat
.025
.1
.02
.08
4'(=)
Chlorthiophos,
plasma
RBC
dog (beagle)
<.025
.025
.05
.025
1-
s
Ethion, dog
plasma .025 .15 t
Chlorpyrifos, rat
plasma
RBC
<.3
<.3
.15
.15
.1
.1
i{?)
i(?)
Dimethoate, rat
plasma      .1^
RBC        .7"^
.16
.16
.05
.05
4.
4
Aldicarb sulfone, rat
plasma
RBC
2.4
2.4
1.2
1.2
.6
.6
SD:  Sprague-Dawley strain
Studies from sample, described in Appendix III-3
Trend as increase study length: 4' indicates NOEL dec¬
reases as study lengh increases; T indicates NOEL in¬
creases as study length increases; = indicates no
change
Dosing by intraperitoneal injection
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III. Dose-Response Assessment
A.  Approaches to Dose-Response Assessment
There are four main appproaches to using experimental dose-
response data to obtain estimates of a response at low, policy-
relevant doses:
1) the NOEL uncertainty factor approach
2) the "benchmark dose" uncertainty factor approach pro¬
posed by Crump (1984))
3) mathematical modeling of the entire dose-response curve
4) linear extrapolation.
NOEL-Uncertainty Factor Approach
In this approach, an acceptable daily intake (ADI) is esti¬
mated by
ADI = iiOHL____________
uncertainty factor
where the NOEL is the "no observed effect level," defined by EPA
as
The level (quantity) of a substance administered to agroup of experimental animals which demonstrates theabsence of adverse effects observed or measured at
higher dose levels. The NOEL produces no biologicallysignificant difference between the group of chemicallyexposed animals and an unexposed control group ofanimals maintained under identical conditions.
[U.S. EPA, 1985] (Emphasis added from earlierversion.*)
Underlined terms were omitted in the definition written
the decade before by three OPP scientists in "UnitedStates Pesticide Tolerance System" as reported in U.S.House of Representatives (1983) Regulatioi^ of Pesti-Cljlaa: Appendix to hearings before the Subcommittee onDepartment Operations, Research and Foreign Agricultureof the Committee on Agriculture, 98th Congress FirstSession   (serial   No.   98-22   vol.   III).
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An ADI is defined as the amount of toxicant in milligrams
per kilogram bodyweight per day (or in milligrams per day for a
70 kg person) which is not anticipated to result in any adverse
effects after chronic exposure to the general population of
humans, including sensitive subgroups [U.S. EPA, 1980]. An un¬
certainty factor is a number intended to account for the uncer¬
tainties in using a response at a single dose (the NOEL) from an
experimental study to estimate a level of risk for the diverse
human   population.
Traditionally, the uncertainty factor is a multiple of 10.
The appropriateness of selected values for uncertainty factors
for ChE-inhibiting pesticides has been an area of debate within
the Agency, reflecting the larger debate over uncertainty factors
in general. The determination of a NOEL for these compounds is
also controversial.
EPA uses the NOEL-UP approach for ChE-I pesticides and other
substances (referred to by EPA as "systemic toxicants") believed
to exhibit a threshold (EPA, 1986). This approach is not
considered appropriate for agents that do not exhibit a
threshold, which is usually the assumption for carcinogens. The
NOEL, although actually a subthreshold dose level, is used to
estimate the threshold dose, which in reality lies between the
true NOEL and "lowest observed effect level," or LOEL. The
measurement of the actual or true NOEL, LOEL, or threshold dose
is a "trans-scientific" problem [see Section V] since these
values can not be measured due to practical limitations on the
size and sensitivity of experiments. The term threshold is
generally applied to individuals, although in establishing an
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ADI, a population threshold is implied. A population threshold
is theoretically the threshold of the most sensitive individual
in a population [EPA, 1986].
In keeping with the approach recommended by the NRC (1983),
EPA conceptually separates risk assessment from risk management,
and recommends that the term "reference dose" (RfD) be used in
lieu of "ADI" [EPA (1986)]. It is argued that the use of the
value-laden word "acceptable" is inappropriate in the largely
scientific process of risk assessment. Other non-scientific
factors also determine what level may be considered "acceptable."
Use of the term ADI implies that doses higher than the ADI are
"unacceptable" and that all doses less than the ADI are "accept¬
able" or "safe." In reality, there are many uncertainties in
estimating an ADI which do not permit such a strict interpre¬
tation. The concept of a "reference dose" (RfD) is presented as
a dose to be used as a reference point for gauging the potential
effects of other doses, as a way of circumventing these connota¬
tions. For similar reasons, the term "uncertainty factor" is
preferred over "safety factor." The RfD is estimated in the same
way as an ADI. The more the RfD is exceeded (both in frequency
and in magnitude), the more likely it is that adverse effects may
be observed in a human population. Likewise, the more the EfD is
avoided (in frequency and in magnitude) the less likely it is
that adverse effects may be observed in a human population.
"Benchmark Dose" — Uncertainty Factor Approach
In response to criticisms of the NOEL-UF approach (e.g.,
problems in measuring a NOEL), Crump (1984) suggested a new
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method for determining ADIs which uses a "benchmark dose" (BD) in
lieu of a NOEL. He defines the BD as the statistical lower
confidence limit of a dose producing some predetermined increase
in response rate such as 0.01 or 0.1 percent. Although the BD is
calculated using a mathematical model, this approach is different
from the mathematical modeling approach described below since it
does not attempt to model the response at low doses. In fact,
the particular model used is not very important since the method
does not involve extrapolation much below the experimental range.
This approach can be applied either to data where responses are
quantal ("all or none") or (as is the case with ChE-I) to con¬
tinuous ("graded") responses. It also requires the use of
uncertainty   factors.
Mathematical   Modeling  Approach
This approach is used by EPA to assess the risks of sub¬
stances believed to pose a risk at any dose, no matter how small
(e.g., carcinogens). For these non-threshold toxicants, a mathe¬
matical model is fitted to animal dose-response data and used to
predict risks at lower doses which correspond to those experi¬
enced by humans. The choice of a model, although partially
based on biological plausibility, is a matter of policy (degree
of conservatism), since the choice of model can result in risk
estimates which may differ by orders of magnitude. There is no
inherent property of threshold toxicants which renders them un¬
suitable for dose-response modeling; the choice of the NOEL-UF
approach for these compounds appears to be largely based on
tradition.
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Two types of models are often used: (1.) tolerance-
distribution models and (2) stochastic or probabilistic models.
Tolerance-distribution models assume that every person in the
population has their own tolerance to the toxicant. These models
(which include the probit, log-probit, logistic, and Weibull) can
be used for "non-threshold" toxicants by assuming that the popu¬
lation tolerance (the minimum of the individual tolerances) is
zero. A number of factors (e.g., gender, race, diet) appear to
affect individual susceptibility to ChE-I pesticides, so that the
assumption of a distribution of tolerances appears to be well
founded for these (and many other) compounds. In contrast, the
stochastic models (which include the one-hit, multi-stage and
multi-hit) assume that a response happens as a consequence of a
random occurrence of one or more biological events, and that each
individual in the population has an equal probability of respond¬
ing. The one-hit, multi-stage, and multi-hit models were derived
from theories on the mechanism of carcinogenesis, and are not
applicable to ChE-I pesticides. However, it is possible that
other stochastic models (based on our knowledge of the mechanism
for ChE-inhibition) could be developed. The merits of one such
model   (Wilkinson,  1983)  will be discussed.
Linear Extrapolatign  (Interpolaticn) ftpprcach
Partially in response to the criticism that the choice of a
particular mathematical model could not be scientifically justi¬
fied, the U.S. Food and Drug Administration adopted a procedure
recommended by Gaylor and Kodell (1980) for dose-response assess¬
ment  of carcinogens  which does not depend on any mathematical
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model for extrapolation. This procedure assumes that the dose-
response curve has a sigmoidal shape (a fundamental toxicological
premise supported empirically), and rather than providing an
estimate of risk in the low dose region, it places an upper limit
on the potential risk at low doses. This procedure consists of
four steps:
1) Approximate the dose-response relationship in the
experimental data range using any appropriate mathe¬
matical model which adequately fits the data.
2) Obtain the upper confidence limits on the response
above background (control) levels in the experimental
dosage range,
3) Connect a straight line from the origin to the point
representing the upper confidence limit at the lowest
experimental dosage.
4) Obtain upper limits of risk for low dosage or dosages
corresponding to upper liiaits of small risk from the
interpolation line obtained in step 3.
Note that although the interpolation line goes through the
origin, this does not imply that it assumes a no threshold
response, since it provides an upper limit, not an estimate, of
the actual risk in the low dose region. The procedure is
actually interpolative since it is estimating a value between two
known data points. Several variations of this basic procedure
have also been suggested (Krewski et al. 1984).
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B.       Selecting  the  Best Approach
A key consideration in the choice of a dose-response assess¬
ment method is the way in which uncertainties necessarily
involved in low dose extrapolation are handled. Since the goal
is a consistent and rational risk assessment policy, the approach
should be justifiable on scientific and policy grounds. With
this in mind, each of the possible approaches can be evaluated
using   existing  data  on  ChE-I  pesticides.
1.       NOEL-UF  Approach
Although the NOEL-UF approach has been the method used for
threshold toxicants for many years by many agencies, using this
approach for ChE-I  pesticides  has  some  limitations,  including:
1) the uncertainty regarding the meaning and estimation of
a  NOEL  for  ChE-I
2) the uncertainty regarding the appropriate UP to use
when calculating an ADI for ChE-I pesticides
3) the effect of study design on establishment of a NOEL
(e.g.,   sample  size  and choice of  experimental  doses)
4) neglect of available information on the dose-response
relationship
5) it is not a cost effective way of using available data.
As discussed in the Hazard Identification section of this
report,   there are several uncertainties in regard to establishing
a NOEL  for  ChE-I:
1) What is the biological significance of ChE-I? How does
ChE-I relate to impairment of normal physiological
functioning?
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2) Is it possible to establish a biological threshold for
ChE-l that is indicative of a NOEL? If so, how should
it be measured?
There are several science policy options for handling this
uncertainty:
1) Establish a level of ChE-I which will be considered an
effect for regulatory purposes, stipulating the
parameters under which it will be applicable. Th'ese
parameters may include:
a) whether post-exposure values of ChE are to be
compared to control values or to pre-exposure
values to determine the amount of inhibition
(e.g., in a species with a large degree of intra-
species variation in ChE values, such as humans,
comparison to pre-exposure levels may be much more
meaningful.
b) number of pre-exposure baseline determinations
(e.g., a fall in activity could be regarded as
significant  (p < .05)  if it exceeds a value given
by the expression [1.65 s->/n+l]/n (Gage, 1967*)
where s is the standard deviation around the indi¬
vidual average and n is the number of determina¬
tions on which the pre-exposure average is based
* The  expression  given   in  Gage   (1967),   cited  from Callaway(1951) is 1.65s -sV(n+l)n which appears to be in errorsince increasing pre-exposure baseline determinations (n)decreases the degree of inhibition needed to showstatistical  significance  (thus divide by n,   not multiply).
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c) site and type of ChE measured (e.g./ a smaller
amount of brain AChE-I may be more significant
than AChE-I in erythrocytes)
d) length of study/age of animal (e.g., a comparison
of pre-exposure ChE levels when an animal is young
with post-exposure ChE levels near the end of its
life span may be confounded by age)
e) species or strain of experimental subject (e.g.,
depression of RBC ChE by 25% may be of greater
biological significance in rabbits than dogs)
f) measurement method of ChE-I
g) type of pesticide (e.g., OP or carbamate)
h)   rate of ChE-I
i)   severity of other effects seen at higher doses.
2) Determine a statistical level(s) for which differences
in ChE measurements will be considered significant for
regulatory purposes (e.g., p < 0.5), stipulating the
conditions under which it will be applicable (see a-i,
above).
3) Specify the conditions for which ChE-I per se may not
be an adequate toxicological endpoint (e.g., carbamates
for which the inhibition of ChE is rapidly reversible).
4) Use a dose-response assessment approach that does not
require the establishment of a NOEL (e.g., for all ChE-
I, or only for some, such as carbamates).
5) Incorporate this uncertainty as a component of the UF.
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The second criticism concerns the choice of an UF. What
factors should be considered in establishing the UF? How should
they be quantified? Various federal governmenal agencies and
scientific organizations have recommended different UFs, as
summarized in Table III-l. However, the actual UF employed does
not always adhere to these recommendations. For example, a
variety of UFs have been used in calculating ADIs (RfDs) for ChE-
I pesticides. These may be justifiable in light of the recently
articulated "modifying factor" (MF). To assure consistency in
the selection of a MF, some sort of guidance will be required.
There have been various attempts to justify the selection of
UF values, with little success. Dourson and Stara (1983) of EPA
have characterized the uncertainty represented by a lOOX UF as
being basically of two types: interspecies variability and
intraspecies variability. Most of the justifications for a lOOX
UF given in Table III-l fall into one of these two categories,
with the exception of uncertainties arising from possible syner¬
gistic action with other contaminants,and small sample sizes. A
lOX UF is generally ascribed to interspecies and intraspecies
variability. Section IIIC documents the evidence to support an
UP for these two types of uncertainty in the dose-response
assessment of ChE-I pesticides, in an attempt to resolve some of
the controversy over the most appropriate UF to choose.
The third criticism of the NOEL-UF approach is its depend¬
ence on study design. EPA's use of this approach discourages a
registrant from planning more sensitive studies using a large
number of animals. A larger study has a higher probability of
showing a statistically significant result at a given dose level
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and thus will more likely result in a smaller ADI.  Gaylor (1983)
illustrates this using results from two hypothetical experiments:
Proportion of diseased animals (%)
Dose Units Ej^££j:iment 4 E3tp£7.inierLt_B
0 0/20  (0) 0/60  (0)
1 1/20  (5) 3/60  (5)
2 2/20 (10) 6/60*(10)
3 10/20*(50) 30/60*(50)
* Statistically different from control (p < .05)
Although the results of both experiments are proportionally
identical, the NOEL in experiment A is 2 and in B is 1 dose unit.
This is because the results at 2 dose units are statistically
significant only at the p < 0.244 level in Experiment A, whereas
in B they are significant at the 0.05 level. Dividing by an DF
of 100 yields an ADI (RfD) for Experiment A of 0.02 dose units
and 0.01 dose units for B. We would have expected Experiment B
to produce a larger ADI than A since there is less random varia¬
tion, but that is not the case if this approach is used.
Another study-design related concern in using the NOEL-OF
approach is the selection of experimental doses. The highest
true NOEL may be anywhere between the NOEL determined in the
study and the LOEL. Thus, the NOEL is either an unreliable
estimator of the threshold dose (assuming a threshold exists).
Or, it may not be possible to determine a true NOEL if it is
above or below the experimental dose range. Proponents of the
NOEL-UF approach might counter these criticisms by pointing out
that Good Laboratory Practice Standards and other EPA guidelines
specify the minimum numbers of animals/dose level to ensure an
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adequate study design. Although this ensures that "unacceptably"
small (i.e. substandard) studies will not be used, studies using
larger than the minimally acceptable sample size to demonstrate
greater evidence of safety are discouraged.
One partial solution to this problem (of discouraging large
sample sizes) would be a policy guiding the use of m.odifying
factors (MFs). Sample size is, in fact, cited as a justification
for employing a MF other than the default value of one in a draft
EPA concept paper introducing the term MF (EPA, 1986). However,
without a risk assessment policy in place to offer guidance,
different scientists will likely select different MFs in a given
case, since the value is largely arbitrary. Such inconsistency
is scientifically unjustifiable and would undoubtably leave the
Agency vulnerable to charges that personal values had entered
into the risk assessment. In contrast, a well-established policy
regarding the use of MFs could encourage larger, more accurate
studies.
The fourth major criticism of the NOEL-UF approach is that
it ignores dose-response information, since the NOEL is limited
to the dose levels tested. Two alternatives are possible: (a)
utilize a different approach, such as the BD concept, or (b)
develop a risk assessment policy based on the dose-response curve
to guide the choice of MFs. Since uncertainty in the estimation
of a NOEL can result in a much greater underestimation of risk
when the dose-response curve is steeply rather than shallowly
sloped, larger MFs could be applied.
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Lastly, the NOEL-UF approach does not use available data
cost-effectively. In three out of five studies attempting to
determine subchronic or chronic NOELs for ChE-I cited in an EPA
risk assessment document for parathion (Ghali, 1985), NOELs for
ChE-I could not be determined since effects were observed at all
doses tested. Under the current approach, the only information
gleaned from these studies (which can cost between $500,000 and
$1 million) is that the NOEL is less than the lowest dose tested.
If another approach was used, this same data could be utilized to
estimate that dose producing some small additional level of risk.
2)   Benchmark Dose (BD)-UF Approach
The BD-UF approach suggested by Crump (1984) was developed
in an attempt to respond to the criticisms lodged against the
traditional NOEL-UF approach. Specifically, it addresses the
following criticisms of the traditional approach:
the effect of the study method in establishing a NOEL:
larger experiments tend to produce larger BDs (in con¬
trast with NOELs) and BDs are not limited by having to
be one of the doses tested.
the disregard of existing information on the dose-
response relationship: BDs reflect the dose-response
pattern to a much greater degree than NOELs, since
estimation of the BD involves fitting a model to the
dose response data.
- the inability to make cost-effective use of data: any
properly conducted and reported study can be used to
calculate a BD, unlike a NOEL.
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— the uncertainty  regarding  the meaning  and  estimation  of
. a NOEL:     although it  is true that  it  is not necessary
to   define   a   NOEL   to   determine   an   R^D   using   this
approach,    the   biological   significance   associated   with
the dose used  to determine  the RfD  remains unresolved.
For  continuous  data   (such  as  ChE-I)   the  BD   is  defined   as   the
dose   which   corresponds   to   a   specified   amount   of   absolute  change
in the mean value relative to the mean value in the absence of
the   dose   (the   "extra   response"):
BD = m(d)   - m(Q)
m(o)
where d = dose and m(d) = mean response at dose d.  Since ChE-I
is a continuous response showing a smooth dose-response trend it
is difficult to pinpoint a threshold for a given subject and even
more difficult for a large human population.  If it is assumed
that exposure to ChE-I pesticides is capable of producing some,
albeit immeasurable, inhibition of ChE, a policy decision could
be made to establish what portion of the extra response (%) would
constitute the BD.
Crump suggests three models for continuous data:  (1) the
continuous linear regression (CLR) model
m(d) = c + q2(d - dg)    for d 2 dg
= c for d  < dg
where  dg  ^ 0  and c  and q^  are unrestricted,   (2)   the continuous
polynomial  regression  (CPR)   model
m(d)   = c  + qj^   (d  - dg)   +   ...   + q,^ (d  -  dg)'^   for  d 1 dg
= c for d  < dQ
III   -   14
where dg 2. 0 and qj^'s are either all positive (increasing dose
response) or all negative (decreasing dose response) and (3) the
continuous power   (CP)   model
m(d)   = c   + q2(d  - dg)k.
The assumption is made that the responses of subjects in a
dose group are normally distributed with mean m(d|) and variance
cy^^' With this information a maximum likelihood estimate can be
computed. Unfortunately, ChE-I data is often reported as mean
ChE/dose group, without reporting the variance. Since the ani¬
mals used in a given experiment are genetically homogeneous, one
could assume a relatively small variance. However, as Figures
III 1-4 show, this may not be a valid assumption. When investi¬
gators do not  report  variance,   these methods can not be used.
As with the NOEL-UF approach, there is also the problem in
selecting the apropriate UF. Gaylor (1983) suggests an alterna¬
tive to the use of UFs (Table III-l) in which the size of the
safety factor is chosen so that a specified low level of disease
risk will not be exceeded. Although Gaylor uses quantal data,
continuous data may also be used. Once the BD is estimated for a
predetermined extra response (say, 10% above controls), then (a)
select (via a policy decision) the level of extra response which
is of interest for the study ("acceptable") (e.g., 1 in 1,000
animals, or R = 0.001), (b) determine the upper confidence limit
(e.g., 95%) on the percentage of extra response associated with
the BD (call this value D), (c) calculate UF = U/R, (d) calculate
RfD = BD/UF.     This  method  of determining  UFs  can  also  be  used
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with   the   NOEL-UF   approach.      Appendix   III-l   illustrates   this
method  using  actual  data  for ChE-I  pesticides.
3)       Mathematical Modeling  of Dose-Response Curve
It seems paradoxical that mathematical models have been
developed to describe carcinogenesis, which is so little under¬
stood, and not ChE-I, for which detailed knowledge of the
mechanism of toxic action is known and which is an effect caused
by the majority of insecticides in use in the U.S. (see Introduc¬
tion). For example, Awad (1984) has described the molecular
mechanism and rate equations for ChE-I by malathion. Although it
is beyond the scope of this paper, it would certainly be worth¬
while to take advantage of the available literature and explore
the use of kinetic models, as well as tolerance distribution
models already developed (such as the probit) for dose-response
assessment  of ChE-I   pesticides.
Wilkinson (1983) has in fact developed a kinetic model for
aldicarb, using available human data. Data on whole blood ChE-I
over time (t) for each dose were fitted to an exponential
equation:
-k^t    -k.t
Y = A  (e e )
where kj^ is the rate of ChE-I
kj. is the rate of ChE recovery
and A is the Y intercept (of the recovery portion of the curve).
When using the available human data, this model (1) bypasses
the need for interspecies extrapolation, (2) the dose aproximates
the exposure condition of interest (i.e., exposure via aldicarb-
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contaminated water) and (3) dosing conditions represent the
worst-case situation (i.e., single bolus). The principal disad¬
vantages of the data used were the small sample size (only 12
subjects), whole blood ChE was measured rather than ChE in RBC
and plasma, and the study was never published. However, our
principal interest is in the merits of this method of dose-
response assessment, not the data used in Wilkinson's example.
It addresses several of the criticisms of the NOEL-UF approach:
1) It does not require the definition of a "NOEL" or
threshold level. It assumes that any exposure to aldi-
carb is capable of producing some ChE-I, even if not
measurable. ChE-l is thus used as a measure of expo¬
sure, not effect.
2) Mathematical modeling does not generally employ UFs,
thus bypassing this controversy.
3) The limitations of the study design are not as pro¬
nounced as with the NOEL-UF approach, although still
may be present, Wilkinson averages the values of kj^,
k^, and A obtained for each of the doses used to obtain
the general form of the equation, which is then used to
predict the effects at other doses. The general form
of the equation tends to predict somewhat higher values
of ChE-I (except immediately after dosing) than do the
dose-specific equations. Using a larger number of
doses would reduce the overestimation predicted by the
general form of the equation, thus rewarding studies
with a larger number of doses. Uncertainty resulting
from small sample size, on the other hand, does not
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appear   to   be   considered.      Other   mathematical   modeling
approaches   (e.g.,   probit)   do  consider   sample   size.
4) Mathematical modeling does utilize information from the
dose-response   relationship.
5) Wilkinson's modeling approach can be used for studies
in which NOELs can not be established, as long as data
on ChE-I over tiiiLa are provided. This approach could
obviously not be used for many studies, but is a cost-
effective way of using single dose human studies which
otherwise might not be utilized to determine a RfD.
The level of ChE-I from repeated exposures over long
periods of time can be estimated if the following
assumptions are made: (a) subsequent exposures occur
before the effects of previous exposures are elimi¬
nated, (b) the magnitude of all exposures is similar,
(c) the intervals between exposures are equal, and (d)
the kinetic parameters remain constant throughout
exposure.
Another advantage to the mathematical modeling approach is
that the effects of these and other assumptions can be explored.
Assumptions that have a large effect on estimates of doses or
responses can be  explored  in more detail.
In conclusion, the mathematical modeling approach is an
alternative to the NOEL-UF approach which merits more attention,
through validating existing models (such as the kinetic model for
aldicarb by Wilkinson  et  al.)   and   through  research  into  other
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models, particularly for data which is applicable to the human
experience and could otherwise not be used to determine a RfD.
4)   Linear Extrapolation
While linear extrapolation may often be thought of as a type
of mathematical model, it can also be interpreted as a variation
on the NOEL-UF approach. Rather than connecting a straight line
from the origin to the point on the upper confidence limit at the
lowest experimental dosage (step 3 of procedure listed previous¬
ly) to obtain the upper limits of the response at a low dose, an
equivalent procedure is to divide the upper confidence limit (U)
on the response produced by the NOEL by a (policy predetermined)
extra response of interest R (say, R = 1% ChE inhibition) to
obtain an UF = U/R (Gaylor, 1983).
The RFD is then obtained as usual by dividing the NOEL by
this UF. This approach can also be applied to an ED (e.g. EDgg
representing 10% ChE-I). This is illustrated in Appendix III-l
using data for parathion.
The main advantages to linear extrapolation are that:
1) an upper limit on the level of risk in the experimental
population can be obtained, since as the dose is de¬
creased, the risk response decreases proportionately
more rapidly  (zero is the lower bound on the risk),
2) the influence of sample size is controlled through the
use of confidence limits (so that smaller experiments
are not rewarded by higher allowable doses),
3) the problem of selecting or developing an appropriate
mathematical model is circumvented,
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Applying this approach to an ED (dose for which the BD is an
upper limit) also incorporates many of the advantages attributed
to the BD-UF approach (e.g., a threshold dose need not be
demonstrated).
Summary
In conclusion, there are situations in which each of the
four approaches to dose-response assessment of ChE-I appears to
be advantageous. When information on kinetics and resources to
develop, refine and validate the method are available, a mathe¬
matical modeling approach is desirable. When ChE-I data is
expressed as mean ChE activity ^ standard error, the BD-UF or
linear  extrapolation approach are desirable.
Finally, the NOEL-UF approach can be.used in the remaining
situations, if the recommendations outlined for developing a
clear, sound science policy are followed. Policy that allows
some flexibility in the choice of dose-response assessment
method    will  result in a more productive use of available data.
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C.       Selection  of  Uncertainty Factor
1.        Animal   to  Human   Eytrapolation
In an attempt to quantitatively estimate the uncertainty in
extrapolating experimental results from animals to humans, human
NOELS for ChE-I were compared to other animal NOELs for nine
pesticides  (Appendix III-3). Unfortunately, differences  in
study design and inadequate reporting of human data in several
cases made valid comparisons difficult. Much of the human data
were collected on prisoners or "volunteers" (usually male) and
thus did not reflect the human population at large. Individual
body weights of human subjects were not always reported. The
experiments on humans were typically of shorter duration than the
animal experiments to which they were compared, making such
comparisons questionable. In two instances human and animal
studies of ChE-I were of comparable duration:
Malathion:
Rat   (RBC)   ChE-I  NOEL   (33 day)           5.0  mg/kg--------------------------------------------------=------------------= 21.7
Human   (RBC)   ChE-I  NOEL(47  day) 0.23  mg/kg
Diraethoate:
Rat   (RBC,   plasma,   and brain)   ChE-I  NOEL(34  day)       0.7  mg/kg--------------------------------_------------------------------------------=   --------------= 3^5Human   ("whole blood"  and RBC)   ChE-I NOEL(39 day)     0.2 mg/kg
This implies that healthy adult men are 22 times more sensi¬
tive to ChE-I by malathion than rats, and adults (presumably
healthy men and women) are 3.5 times more sensitive to ChE-I by
dimethoate than male rats. However, this should be interpreted
cautiously since   (for  malathion):
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o Only 5 men   (prisoners)   were  tested with malathion
o Body weights of men were not  recorded   (assumed  70  kg)
o Dosing   procedure   was   not   clear   (e.g./   not   indicated
whether  dosed  on  full   or  empty  stomach),   although both
rats and humans were dosed orally
o Dosing   schedule  was  unusual   (i.e.,   administered   8 mg   to
each man every day for 32 days, gave no treatment for 3
weeks,   then  administered  16 mg/d  for  47  days)
o Age of rats and men not reported in available reviews
(assumed  adult  age)
and  for dimethoate:
o        Only nine humans  (gender not reported)  were tested at
this dose level
o        Route   of   administration   differed   (intraperitoneal   in¬
jections  for  rat and oral  aqueous solution  for  humans),
o        Age of   rats and humans not  reported   (assumed adult age)
However,   the  human  study of  dimethoate  was   rated   as   "supplemen¬
tary upgraded to minimum" by EPA's Office of Pesticide Programs
and "High Confidence" by EPA's ADI work group.     The human study
of malathion  is  the basis  for  the ADI  set by the World Health
Organization   (WHO,    1982).
Table III-2 compares NOELs for studies of comparable length
among different species. Studies where the NOEL was lower than
the lowest dose tested or higher than the highest dose tested
resulted in minimum or maximum ChE-I ratios (e.g., (Rat NOEL)/
(Dog  NOEL)  1 1.9,   implying   that  the dog   is  no more than 1.9 times
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more sensitive to ChE-I by chlorthiophos than the rat). Inter¬
species differences ranged from no difference (ratio = 1) to
greater than 25 fold difference (x=5*). Comparisons made on a
per unit surface area basis rather than a weight basis did not
consistently reduce the  variability observed.
Comparisons of sensitivity to ChE-l pesticides among non-
human species is useful in estimating the uncertainty in animal-
to-human extrapolation because (a) if different species of test
animals differ from each other in sensitivity, it is likely that
humans will differ from test animals and (b) directly comparing
the sensitivity of humans to test animals is difficult due to
scanty reliable human data and ethical prohibitions against
collecting additional  human data.
Due to the small number of comparisons which were made and
differences between studies (e.g., in how, when, and for how many
animals ChE levels were measured), no firm conclusions can be
drawn  from the data  in Table  III-2.     However,
a) Dogs are often (but not always) more sensitive than
rats   to  ChE-I.
b) ChE-I measured at a particular site (i.e. plasma,
erythrocytes, or brain) did not vary more (across
species)   than  at  other  sites.
Mean calculated after inverting ratios less than one, andassuming minimums and maximums represent the actual ratio(note that the number of minimum ratios balances the number
of   maximum   ratios).
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c) ChE-I measured after chronic exposure did not vary more
V.across species than ChE-I measured after subchronic
exposure to the pesticides analyzed.
d) Humans were more sensitive to ChE-I than rats in the
two instances where comparisons could be made.
Edson (1964) conducted several studies comparing ChE-I NOELs
in the rat, pig, and human. This reduced the variability expected
when studies conducted in different laboratories are compared.
These results are shown in Table III-3. One problem in esti¬
mating NOELs from these studies is that only a qualitative
description of some of the results is provided. For example,
when Edson reports that "Red cell ChE was slightly reduced at
0.025 ppm," it is not apparent whether this dose is the NOEL or
LOEL. The difficulties are compounded by inconsistencies in the
article summarizing the data. For example, he reports 0.05 ppm
as the NOEL for rats exposed to parathion, yet concludes that the
NOEL is 0.02 mg/kg/d. According to the diet conversions used by
the ADI work group (from Layman's tables), the percent of body
weight consumed as food, F, is 0.05 for rats, and F times X ppm
of pesticide in feed is 0.05 x 0.05 = 0.0025 mg/kg.
The ratio of ChE-I measured in red blood cells ranged from 1
to 48 and from 1 to 480 (and possibly as high as 960, depending
on the interpretation of Edson's data) in plasma. These results
should also be interpreted cautiously (due to small sample sizes,
variable dosing schedules, poor reporting of data, etc); however
much of the uncertainty in the data which would result from
different study designs, methods, individual techniques, and
scientific judgment were probably minimized.
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Undoubtably  the  major   factor   contributing   to   the   inter-     (^
species   variation   in   sensitivity   to  ChE-I  pesticides   is  differ¬
ences   in  metabolism,   although  differences   in   absorption,   plasma
protein binding,   and other  factors also play a role.     Table III-4
provides   some   examples   of   these   differences    (from   Hollingworth
(1971) and  Calabrese   (1983)   reviews  of  the   literature on  compara¬
tive metabolism and sensitivity to OPs and carbamates.)     Wills
(1972) provides estimates of the "normal" activities of red blood
cell and plasma cholinesterases in 15 species. Humans have the
highest activity of plasma ChE of the 15 species compared, about
15 times the activity of rabbits (the largest difference) and
twice that of dogs. Estimates of plasma cholinesterase in rats
varied greatly (22 fold for males, even when measured by the same
method), probably due to strain differences. Humans, rabbits
and pigs had higher ChE activity in RBCs than in plasma, although
the opposite was true in the dog. Exactly how differences in ChE
activities may translate to differences in susceptibility to ChE-
I pesticides is unclear, although it is interesting to note that
the species with high ChE activities (human, monkey, dog)
generally appear to be more susceptible (Tables III-2 and III-3)
than those with lower ChE activities (rat, mouse). According to
Wills, the ChE in the blood of various species seems to fall in
the following order of decreasing concentration: human, horse
and monkey, cattle, turkey, dog, rat, duck, cat, goose, mouse,
and rabbit. Only in 3 of the 24 comparisons shown in Table III-2
was the correlation between higher ChE activity and greater
sensitivy to ChE-l  pesticides not  as predicted.     These three were
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comparisons between the rat and dog. Some of the estimates given
by Wills for the plasma ChE activities of the rat were lower and
some higher  than  those  for   the  dog.
In addition to differences in ChE activities across species,
other differences in metabolism also contribute to interspecies
variability in response to ChE-I pesticides. Serum paraoxonase
activities are higher in rabbits than in rats, for example (La Du
and   Eckerson,   1984).
2.       Variation   in   Human   Sensitivity
Section IIB outlined the major factors accounting for (or
potentially contributing to) differences in sensitivity among
people to ChE-I pesticides. Factors which generally seem to be
(or are likely to be) associated with increased sensitivity
include young age (including pre-natal), genetically determined
ChE and arylesterase (e.g., paraoxonase) with low activity, preg¬
nancy, food or water deprivation, malnutrition, stress due to
temperature or viral infection, and exposure to certain other
substances (e.g., other ChE-I's, alcohol, nicotine, chlorproma-
zine). Certain disease conditions may also contribute to
enhanced sensitivity to ChE-I pesticides (e.g., anemia, liver
disease, carcinoma, epilepsy, renal ischaemia, schizophrenia,
eczema). Since ethical prohibitions prevent the deliberate expo¬
sures of potentially high risk individuals to pesticides under
controlled experimental conditions, it is difficult to quantita¬
tively determine with certainty the variation in human sensitivi¬
ty to ChE-I pesticides. The contribution of some of the above
mentioned   factors   to   increased   sensitivity   in   animals   sometimes
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exceeds the customary ten-fold factor for intraspecies variation.
For example (see Section IIB) chlorpyrifos (used to control
parasites in cattle, and widely used for indoor pest control) is
thirty times more toxic to calves than adult cattle, and
malathion (also widely used in the home or by homeowners) is
twenty-eight times more acutely toxic to newborn rats than
adults.
3.   Recommendations
The evidence adduced in Sections IIB and HID indicates that
an uncertainty factor as small as ten is clearly inadequate to
account for the inter- and intraspecies variability in response
to ChE-I pesticides. Ten is the UF usually applied to NOEL's
based on Che-I, even when derived from an animal study (Federal
Register,    1981).
In keeping with the recommendations of NAS, WHO, FDA, and
EPA (for,non-carcinogenic compounds other than ChE-I pesticides),
it is recommended that an uncertainty factor of one hundred be
used when employing the NOEL-UF or BD-UF dose-response assessment
methods. In cases where available data demonstrates that the
inter- and intra-speciea variation is significantly different
from one hundred, a modifying factor (MF) might be used to
account for this difference. Documentation to justify the selec¬
tion of a MF other than one should be included in the risk
assessment.
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a) May be  a  precursor  of AChE.
b) May be involved in myelin structure (BuChE has been
found in Schwann cells of nerves and between folds of
myelin   in   some  central   axons).
c) May control choline levels in plasma (used to
synthesize ACh).
d) May act as a backup for AChE to destroy circulating
ACh. .    ͣ.    ^^
e) May be involved in structure and/or synthesis of beta-
lipoproteins (is found complexed with beta-lipo-
protein).
f) May removes toxic esters formed by fatty acid
metabolism.
g) May be involved in assimilation of food (serum BuChE
activity decreases after fasting, parallels level of
food intake in undernourished children, and is elevated
in obese and diabetic patients, and persons with hyper¬
lipoproteinemia   (abnormal   lipid metabolism)).
Thus, although BuChE and AChE share many similarities
(mechanism of action, molecular shape, etc.) it is not known how,
if at all, they are related physiologically [Edwards and
Brimijoin,   1982].
Hazard  Identification  Issues Re:ChE-I
Although there are still many questions to be answered, it
should be remembered that AChE has been characterized as "one of
the best studied of all enzymes" [Brimijoin, 1983]. Despite
uncertainties   regarding   the  roles  of AChE  in  erythrocytes  and
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number of muscarinic receptors in target tissues that are capable V
of binding the ACh which accumulates when AChE is being
inhibited,: and in some other cases (e.g. propoxur) due to en¬
hanced enzymatic detoxication.
In spite of this, ChE levels may remain inhibited or
decrease even more in long-term exposures. Figures III-l - III-4
show the inhibition of ChE's in plasma and erythrocytes by
parathion in dogs over two, four, and twelve months. In this
experiment the percentage decrease (from control values) is the
greatest at 12 months at every dose (except for RBC ChE of female
dogs). In other words ChE was inhibited more after one year than
after two or four months. Table II-3 compares ChE-I NOELs for
the same species, pesticide, route of administration, and site of
ChE (i.e., plasma or red blood cell (RBC) but differing study
lengths, for seven pesticides (see Appendix III-3). In the
majority of cases the NOELs are lower in longer (chronic) studies
than in shorter (subchronic) studies. Possible differences in
study designs (e.g., method used to determine ChE-I, comparisons
to unexposed animals vs. pre-exposed animals, strain) and the
small number of comparisons made (16) prevents any definitive
conclusion, but the- results suggest that ChE-I NOELs vary by
duration of exposures such that chronic ChE-I NOELs are lower
than subchronic NOELs. According to Bartholomew et al. (1985), a
decrease (or absence) of acute toxic effects occurs despite
continued inhibition of brain ChE activity and elevation of ACh
concentrations.
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Wills (1972) maintains that "In general, prolonged or re-
Vpeated exposures to inhibitors of cholinesterases have emphasized
the unreliability of estimations of the activities of plasma, or
serum, and red blood cells for judging the severity of intoxica¬
tion by these inhibitors." Levels of ChE-I fluctuate ever the
course of chronic and subchronic exposure. For example, Wills
cites an example in which pigs fed 1.7 mg/kg/day of parathion had
increaged levels of plasma ChE at first, and then decreased
levels until maximum inhibition (43%) occurred on about the 50th
day. RBC AChE levels remained unaffected for 8 days of dosing,
and then fell gradually until maximum inhibition (86%) occurred,
also on day 50. Studies in which ChE activity is infrequently
measured may not be able to determine maximum inhibition. In
addition, there is some indication that the rate of ChE-I may
affect toxicity (Wills, 1972). Jensen (1965) found that the
lethal dose of paraoxon in guinea pigs increases at an increased
rate  of   infusion.
Although tolerance appears to develop to the acute toxicity
associated with ChE-I, what are the chronic toxic effects asso¬
ciated with ChE-I? (Recall that both acute and chronic effects
may result from either acute or chronic exposures). Investiga¬
tions to date have yielded conflicting claims regarding the
existence of chronic neurobehavioral effects (Duffy et al., 1979;
Ecobichon and Joy, 1982; Karczmar, 1984; Levin, 1976; Miller,
1982; National Research Council, 1985, Savage et al., 1982).
These and other chronic effects (carcinogenic, nephrotic) linked
to some ChE-I pesticides or their metabolites will not be con¬
sidered   here.
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Tntraspecies  Variation  of ChE
Not only is ChE activity affected by exposure to ChE-I
pesticides, but it also varies among species (see section HID),
and is affected by age, sex, diet, genetic status, race, pregnan¬
cy, obesity, season, liver disease, myocardial infarction, and
other health and environmental factors. Plasma ChE levels
fluctuate more than RBC AChE levels.
o        Genetic Factors
A small sub-group of the population (estimated by Williams
(1985) to be 4.5%) possess genetically determined atypical plasma
ChE. Atypical ChE was first discovered when the muscle relaxant
succinylcholine, used in anaesthesia, was found to produce an
unusually long period of paralysis and apnea (temporary suspen¬
sion of breathing) in some patients. These individuals were
found to have atypical or low serum ChE, which is responsible for
the hydrolysis of succinylcholine, thus ending the drug's
effects. Genetic studies since then have shown that most people
with atypical BuChE are homozygous for a recessive gene
(designated E^^ E^^^). The gene allele Ej^ directs the synthesis
of a ChE which is unable to hydrolyze succinylcholine at pharma¬
cological doses and which is also less sensitive to certain ChE-
I's (e.g., dibucaine). The latter property is used to classify
serum ChEs, by use of the dibucaine number (DN), a measure of the
degree of inhibition (expressed as a percentage) of serum cho-
linesterase obtained with dibucaine under standardized conditions
(Kalow, 1957). Whereas most people (with normal genotype E^"
E^")   have  a DN between  76   and   81,   those  who  are  heterozygotes
(Ej" Ej^) have a DN between 55 and 69, have about seventy-eight
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instance where other tissues (including brain) were investigated
in a person with atypical serum enzyme, the tissue enzyme was
similarly atypical. It is not apparent whether these people
would be more susceptible to ChE-I pesticides, since their serum
ChE is unable to hydrolyze accumulating cholines; i£££
susceptible, since their serum ChE is less sensitive to certain
ChE-I's (e.g. dibucaine, fluoride); or equally susceptible.
Calabrese (1978) maintains that individuals with such pseudo-
cholinesterase variants should be considered potentially at high
risk to ChE-I pesticides. Calabrese also notes that the dibu¬
caine variant has been found to be extremely sensitive to R02-
0683, and cautions that this is of "particular significance in
light of the widespread use of carbamate insecticides." However,
the OP'S TEPP and DEP isofluorophosphate do not inhibit differen¬
tially among pseudocholinesterase variants and would not cause a
higher  risk  to  those individuals with atypical  variants.
Another indication that genetic factors may affect suscepti¬
bility to ChE-I pesticides is provided through selective breeding
experiments in animals by Overstreet et al. (1979). Male rats
determined to be most resistant and most sensitive to DFP on the
basis of drinking behavior, body weight, and core body tem¬
perature were bred with the most resistant and sensitive (respec¬
tively) female rats in an attempt to establish resistant and
sensitive lineages. Although the former attempt failed,
Overstreet et al. were successful in establishing a sensitive
line of rats. However, the genetic differences in sensitivity
were not  found  to be  related  to differences   in brain or  erythro-
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cyte AChE or serum BuChE activity. The authors speculate that
the genetic differences could be due to changes in sensitivity of
AChE isoenzyme, changes in ACh synthesis or turnover, or changes
in sensitivity of postsynaptic receptors for ACh. Subsequent
studies (Overstreet et al., 1984) have shown that the latter two
factors do indeed contribute to the enhanced sensitivity
observed. Regardless, the data suggests that ChE-I may not
always be an adequate measure of toxicity in genetically-
susceptible individuals.
Besides genetic differences in ChEs, there is another
esterase that is affected by organophosphates and carbamates,
known as arylesterase, for which genetic variants exist.
Arylesterases have not been as well studied as other esterases.
Paraoxonase, an enzyme hydrolyzing paraoxon, the active
metabolite of parathion, is an arylesterase which has been found
to be polymorphically distributed in several populations (LaDu
and Eckerson, 1984). Two alleles determine paraoxonase activity:
A, a low activity allele, and B, a high activity allele. Hetero-
zygotes (AB) also exhibit high activity. About one-half of the
U.S. Caucasian population is homozygous for the low activity
allele (AA), which is speculated to place these individuals at
higher risk of parathion poisoning than those with higher levels
(Ortigoza-Ferado et al., 1984). Non-caucasian populations of
African, Oriental, or American Indian subjects, for example, do
not show the same distribution, but it is not known whether this
is due to the presence of additional alleles or quite different
gene frequencies (LaDu and Eckerson, 1984). Ortigoza-Ferado et
al.   state  "It may be  postulated  that  such differential   suscepti-
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bility would be particularly significant at low or intermediate
levels of exposure to parathion since with marked exposure even
high levels of paraoxonase would not be sufficient for protection
against toxicity." -
It appears, then, that both ChE and arylesterases (e.g.,
paraoxonase) affect the toxicity of ChE-l pesticides. A model
describing the interaction of paraoxon with serum ChE and para¬
oxonase was developed by LaDu and Eckerson (1984). The level of
paraoxonase was found to influence the degree of serum ChE-I in
vitro. The authors recommend that the in vitro model system be
applied to estimate what is likely to occur in vivo, and that
epidemiological studies be undertaken to determine whether indi¬
vidual response to ChE-I pesticides shows the expected relation¬
ship to the type and level of paraoxonase.
o   Sex Differences
Sex related differences in susceptibility to ChE-I pesti¬
cides are most likely to occur for those compounds which require
metabolic activation to produce ChE-I (e.g., parathion). (Doull,
1980). Agarwal et al. (1982) found that the percentage of ChE-I
by parathion was 2.6, 1.2, and 2.7 times greater in female than
male rats measured in plasma, erythrocytes, and brain, respec¬
tively, following a single oral dose. Paraoxon treatment, how¬
ever, resulted in comparable inhibition of plasma, erythrocyte
and brain ChE in both sexes. Castration increased the suscepti¬
bility of male rats to a similar level as females. Pre-treatment
with testosterone enabled these castrated males to recover from
this increased sensitivity, whereas estradiol enhanced their
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sensitivity slightly. Gonadectomy had little effect on ChE
levels in the females. Pre-treatment with testosterone decreased
the sensitivity of ovariectomized females. The authors concluded
that testosterone plays an important role in determining
parathion   toxicity.
While it is well established that the female rat is more
susceptible to the acute toxic effects of parathion (e.g., LD5Q
and ChE-I) than male rats, this sex difference is not as obvious
for chronic or subchronic ChE-I. For example, in a 2 year feed¬
ing study in rats prepared by Daly (1984) for Monsanto (in Ghali,
1985),   no  consistent  pattern   is  observed.
Sex differences exist in absorption, distribution, and
excretion of ChE-I pesticides also. For example, Khaak et al.
(1984) found that less parathion was lost by evaporation from the
skin of male than female rats, males having a larger percentage
of the dose in their carcasses. Similar amounts in both sexes
were excreted in the urine and feces. Although the amount
absorbed from the skin was about the same over a 120 hour period
in male and female rats, males absorbed parathion from the skin
much more rapidly. Females absorbed more in heart and liver
tissue  than males.
The plasma and red blood cells of human males have higher
ChE activities than human females  (Wills,  1972).     Serum ChE is
significantly  decreased   in  women  using  oral   contraceptive  pills
(Robertson,   1967).     How  this   affects   susceptibility  in  humans   is
not clear, although in the rat,  the female is more susceptible
and has higher ChE activities than the male.0        Age
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Kacew and Reasor (1984) report that "it is clear that neo¬
nates are more susceptible than adults to AChE inhibitors."
Although the hepatic cytochrome P450 system which catalyzes some
OPs to their active metabolites (e.g., parathion to paraoxon) is
poorly developed in neonates, neonates are still more sensitive,
apparently due to differences in detoxification, excretion, or
redistribution. For example, the level of the enzyme that
degrades malaoxon (carboxylic ester hydrolase) is less than the
level of the activating enzyme for the first thirty days of life
of the rat. By thirty days of age malaoxon inactivation is equal
to its rate of production (Kacew and Reasor, 1984).
Besides such differences in detoxification ability, the
specific activity of brain AChE increases from a minimum in the
one day old rat, either due to an increase in the amount of AChE
or its catalytic activity (Kacew and Reasor, 1984).
In the human, adult levels of AChE are not reached until
three to five months of age. Even though blood from neonates has
a higher proportion of young cells (which have higher activity
than more mature cells) than adults, AChE activity in newborn
circulating erythrocytes is less (Herz and Kaplan, 1973). Thusr
for a given concentration of ChE-I pesticide, more AChE is
expected to be inhibited in newborns compared to adults (Kacew
and Reasor, 1984). This has been found to be the case with beef
cattle given ChE-I pesticides to control parasites, according to
Kacew and Reasor. Chlorpyrifos is thirty-fold more toxic to
calves than adult cattle. Brodeur and Dubois (1963) compared the
LDjq's of sixteen ChE-I pesticides given intraperitoneal ly for
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twenty-three day old weanling and adult rats. The acute toxicity
was from one to five times greater for weanlings than adults,
except for OMPA, for which adults were five fold more sensitive.
On average, weanlings were twice as sensitive as adults. Mendoza
and Shields (1977) compared the LD5o's of rat pups treated with
malathion (99.3%) by gastric intubation and found that one-day
old pups were three times more sensitive than six day old pups
and nine times more sensitive than eighteen day old piips.
Similarly, the I50 (concentration of malathion required to
inhibit ChE by fifty percent at specified conditions) of one day
old pups measured for brain AChE was one-third, one-fourth, and
one-eighth the amount in six day, twelve day, and eighteen day
old pups, respectively. Lu, Jessup and LaVallee (1965) compared
oral LDgQ's for malathion (99.6%) in rats of different ages and
observed that newborns were twenty-eight times more sensitve than
adults and seven times more sensitive than pre-weaning rats.
They also observed that dividing the dose over four days reduced
the toxicity in adults but increased the toxicity in pre-weaning
rats.
Parathion, malathion and aldicarb all pass through the
placenta and are toxic to the fetus. Malathion and parathion
have been shown to have teratogenic effects [Calabrese (1978),
Fish (1966), Hoffman and Eastin (1981), Wyttenbach and Thompson
(1985), etc.]. Cambon et al. (1979a) found that AChE in the
brain and blood (but not liver) of rat fetuses was consistently
more inhibited than that of the dams treated by gastric intuba¬
tion with aldicarb on the eighteenth day of gestation. Carbo-
furan consistently inhibited brain AChE more in the dam than in
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the fetus, while for pirimicarb, no consistent pattern was
observed. Cambon et al. (1976b) hypothesize that the reason for
the observed differences in sensitivity are due to differences in
fixation of carbamate derivatives on the fetal versus maternal
isoenzymes.
The sensitivity of the elderly to ChE-I pesticides is less
clear than for the very young and unborn. Rider et al. (1957)
found that plasma ChE showed a small but definite increase with
age in both sexes. Other investigators [Galloway et al (1951),
Gage (1969)] did not find age to be a factor influencing the
magnitude of variability of ChE in adults. Ando et al. (1984)
found that serum ChE activity increased according to age in
females, while it decreased slightly according to age in males.
The ChE activity was higher in males than in females under fifty
years of age, whereas the reverse was found in persons over
fifty-five years of age. They also detected seasonal variation
(higher activity in winter than summer) in females but not males.
There does not appear to be any conclusive evidence indicating
that adults of any specific age may be more sensitive to ChE-I
pesticides.
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o   Nutrition
Nutritional deficiencies have been found in some cases to
increase the susceptibility of test animals to ChE-l pesticides.
Parathion, malathion and banol all produced greater ChE-I in rats
on low protein diets than on high protein diets (Casterlme et
al. (1969a, b, 1971 a, b) , Vaishwanar and Mallik (1984)). Para-
thion-induced serum ChE-I was more dependent on dietary protein
levels for subchronically-exposed rats (28 days) than for acutely
exposed animals (single dose) (Casterline and Williams, 1971).
Behavioral changes were noted more often in rats on low protein
diets exposed to parathion or banol than in unexposed rats on low
protein diets or exposed rats on high protein diets (Casterline,
Brodie and Sobotka, 1971). These behavioral changes consisted of
a higher proportion of "No escape" rats (i.e., rats failing to
press a lever to either avoid or escape a negative stimulus
[electric shock] after training in a standard operant condition¬
ing chamber). None of the diet-pesticide groups tested were
associated with significant changes in avoidance only behavior
(lever pressing during conditioned stimuli [light and sound]
preceding the unconditioned stimulus [shock from electric
grids]). In this experiment, although behavioral changes were
noted, the activites of ChE (and monoamine oxidase (MAO)) in the
cerebellum and cerebrum were not significantly affected by the
low casein diet and/or the presence of a ChE-I pesticide. Since
brain ChE can not be assayed until the end of the experiment (at
9 weeks in the parathion experiment and 10 weeks in the banol
experiment), it is possible that inhibition may have occurred
earlier in the experiment, preceding  adaptation to chronic
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exposure. In fact, brain ChE-I was noted in a similar 28 day
experiment by the same investigator (Casterline and Williams,
1971). It is noteworthy that behavioral effects can be observed
following subchronic exposure to a ChE-I pesticide even when
brain AChE levels are not inhibited. Subchronic exposure to
parathion was found to decrease serum and liver triacetinesterase
(AliE) activities in protein-deprived animals as well as ChE
activities, thus reducing the detoxification ability in those
animals and making them highly susceptible to poisoning, even at
low doses (Casterline and Williams, 1971).
In addition to protein (casein), varying dietary levels of
calcium (Ca) and magnesium (Mg) also affected ChE-I by parathion
and band (Casterline and Williams, 1969a). Both high and low
levels of these cations decreased serum and brain ChE-I by para¬
thion and banol. Liver ChE-I was also decreased by parathion and
banol, except by low magnesium which increased ChE-I by para¬
thion. Serum and brain AliE by parathion and banol was un¬
affected or decreased by altered cation levels, while liver AliE-
I by parathion and banol was significantly increased by high Mg
or high Ca in the diet. These results are difficult to inter¬
pret, since they imply that low or high dietary concentrations of
Mg or Ca might decrease susceptibility to parathion and banol
since ChE-I by these compounds is reduced. However, the changes
in ChE and AliE that occurred after pesticide administration did
not influence the lethal action of the pesticides, except with
the casein-free diet, where the mortality was increased.
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Animals on food restricted diets, or deprived of water, were
also shown to be more susceptible to subchronic (via diet) and
acute exposures (via intraperitoneal injection) of parathion and
paraoxon (Baetjer, 1983 and Villeneuve et al., 1978). Food
restriction had a significantly greater effect than water depri¬
vation on blood ChE-l by parathion, but not paraoxon.
In the subchronic study, food restriction increased plasma
ChE-I elicited by parathion, but brain ChE was not inhibited by
the doses of parathion used, either alone or with food restric¬
tion. Increased inhibition of plasma ChE in animals subjected to
food restriction was not observed at the NOEL for the study.
o   Pregnancy
During routine blood ChE monitoring at a pesticide industry,
it was observed that a marked fall in plasma ChE occurred in
pregnant women in their first trimester who had not been exposed
to ChE-I pesticides (Howard et al., 1978). A more extensive
survey by Evans and Wroe (1980) on 941 pregnant women distributed
evenly throughout the 40 weeks of gestation revealed that a rapid
fall occurred in the first trimester to a level which did not
alter significantly during the remainder of pregnancy. Even
lower values were observed in the 105 patients examined during
the week following delivery. Three of the women surveyed
possessed abnormal genotypes (i.e., E^^^ ^l^' ^i^ ^1^' ^"^
Ej E-j^^) and were excluded from the study. Nevertheless, some
women were determined to be at risk to succinyIchol ine on the
basis of ChE activity between 1.68 and 2 units/ml. The numbers
of pregnant women at risk for each time period investigated
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closely paralleled the changes in mean enzyme activity over time,
with the highest risk of apnea and prolonged effects of succinyl-
choline occurring  immediately after delivery.
How do low levels of plasma ChE occurring during pregnancy
affect susceptibility to ChE-I pesticides? Recall that it was
unclear whether individuals possessing non-normal genotypes and
low levels of plasma ChE would be more susceptible to ChE-I
pesticides due to the decreased ability of plasma ChE to hydro-
lyze cholines, or less susceptible since their plasma ChE was
found to be less sensitive to fluoride, dibucaine, and some other
ChE-I compounds. Weitman et al. (1983) found pregnant mice to be
more susceptible to single doses of parathion and paraoxon than
virgin female controls. In pregnant mice, signs of cholinergic
stimulation (tremor, weakness, lacrimation, salivation) were more
intense, brain and plasma ChE activites were lower, blood and
brain concentrations of parathion and paraoxon were higher, and
serum paraoxonase activities were lower, compared to controls.
Whether pregnancy-induced alterations of hepatic function, ChE
activity, serum protein binding, serum esterases or a combination
of these are responsible for the enhanced susceptibility is
unclear,
o        Miscellaneous Health and Environmental Factors
The susceptibility to ChE-I pesticides can be affected by
exposures to physical factors (e.g., cold), biological agents
(e.g., viruses), and other toxic substances (e.g., pesticides,
drugs) .
Not only can the toxicity of ChE-I pesticides be altered in
individuals  with hypo- or  hyperthermia,   but ChE-I  pesticides  may
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have hypothermic effects. Doull (1980) reports that hyperthermia
increases the toxicity of parathion, while Chattopadhyay (1982)
found that half the LD5Q dose of parathion was lethal under cold
temperature.
The percent whole blood ChE-I by DDVP was significantly less
in cold-exposed rats than in rats at room temperature, but by
parathion was significantly more at one-half the LD^g dose and
unaltered at one-quarter of the LD50 dose. Chattopadhyay (1982)
also noted hypothermic efects of OPs in rats under cold exposure.
Body temperature decreased as the dose of O.P increased, and the
higher the ChE-l the lower was the body temperature of the
animals under cold temperature.
Whole-body radiation produces a dose-dependent decrease in
BuCh activity of the ilia in rats and mice, but there is no
significant change in the acute toxicity of ChE-I pesticides in
animals given lethal exposures of whole-body ionizing radiation
(Doull, 1980).
Doses of parathion ordinarily considered sublethal were
lethal to mice infected with the virus MCMV (murine cytomegalo¬
virus), apparently due to a decrease in the ability of infected
mice to detoxify parathion (Belgrade et al., 1984). MCMV is well
established as a model for human cytomegalovirus, a ubiquitous
herpes virus which infects a large portion of the population and
remains with the host in a latent state for a lifetime.
The effects of human cytomegalovirus are usually subclinical
or indistinct, but infections can be manifested congenital ly,
perinatally, in individuals who are immunosuppressed, and in some
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other instances. Serum ChE was inhibited more by infected mice
compared   to uninfected mice.
Synergistic interactions among ChE-I pesticides are known to
occur. Most of the studies of synergism among these compounds
have tested for acute toxicity. According to Doull (1980),
combinations of several OP pesticides fed at "recommended toler¬
ance levels" failed to produce significant synergistic toxicity
in  chronic   feeding   studies. ~
Malathion is potentiated by many OPs since it is detoxified
by carboxylesterases that are inhibited by other OPs. Potentia¬
tion of malathion is known to vary across species. For example,
TOTP (triorthotolyl phosphate) given at a dose which alone did
not significantly affect brain AChE potentiated the anti¬
cholinesterase action of malathion by 29-fold in mice, 17-fold in
quail, 100-fold in frog, 11-fold in sunfish and 12-fold in bull¬
heads (Cohen and Murphy, 1970). Isomalathion and other impuri¬
ties in technical malathion potentiate malathion and are believed
responsible for an epidemic poisoning in Pakistan in 1976 during
a malaria eradication program (Aldridge et al., 1979). Potentia¬
tion of malathion by these impurities is significantly less in
the mouse compared with the  rat   (Umetsu  et al.,   1977).
Potentiation can also occur between drugs and ChE-I pesti¬
cides. For example, chlorpromazine, a tranquilizer, has been
shown to potentiate dichlorvos toxicity in rats, producing about
twice as much ChE-I as dichlorvos alone. Drugs that deplete
glutathione (e.g., acetaminophen) may potentiate the toxicity of
some OPs which are detoxified by glutathione transferases
(Marquis,    1986).
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In contrast, organochlorine (OC) insecticides protect
against the acute toxicity of several OP insecticides. This is
probably because OC's stimulate detoxification of OPs by liver
microsomes and increase noncatalytic binding sites for OPs
(Doull, 1980). Lead was observed not to potentiate parathion
toxicity (Phillips et al., 1973). However, both lead and cadmium
decreased AChE in rat brain following chronic exposure in the
animals* drinking water (Marquis, 1986). Marquis (1986)
summarized her review of heavy metal interaction with pesticides:
"Clearly, the CNS is rendered more susceptible to the hazards of
ChE inhibition in animals chronically intoxicated by heavy
metals."
ChE levels are known to vary with certain disease conditions
(Silver, 1974). A decrease in serum ChE levels has been asso¬
ciated with some forms of anemia, liver disease, carcinoma,
epilepsy, eczema, rheumatic fever, typhus, tetanus, kwashiorkor,
and tuberculosis, while an increase in serum ChE levels has been
associated with diabetes, asthma, obesity, kidney disease, hyper¬
thyroidism and hyperlipoproteinemia (abnormal lipid metabolism).
Patients with mental abnormalities, including psychopathic
patients, had raised levels of serum ChE more often than control
subjects. A decrease in the ChE's of both serum and erythrocytes
has been noted in cases of renal ischaemia. Spastic children
have higher activities towards ACh in serum than either mongoloid
or moronic children, who have activities within normal limits.
ChE levels in erythrocytes are below normal in schizophrenics.
According to a study reported by Silver, the stress associated
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with sitting university examinations can cause an increase in ChE
levels in whole blood from healthy students. Alcohol and nico¬
tine have been shown to depress brain AChE levels. It is not
clear whether or to what extent individuals with these diverse
conditions may have altered susceptibility to ChE-I pesticides.
Individuals  with   low ChE  activities  may be at high risk.
Methodology
Several reviews of the methods for determining ChE activity
are available [Silver (1974), Wills (1972), Augustinsson (1971)].
These methods vary in their accuracy, complexity, efficiency, and
units measured. The conditions to which the enzyme is subjected
differ according to the method used, and thus the results ob¬
tained by different methods are not directly comparable (Silver,
1974). Temperature, pH, substrate, buffer, and contaminants
(e.g. salts, detergents) can affect the measurement of ChE acti¬
vity. Activities may be reported as the change in pH in a weak
buffer solution due to the release of acetic acid from ACh (e.g.,
Michel method); the amount of CO2 evolved from bicarbonate by
acetic acid released from ACh (e.g. Warburg manometric method);
the volume of sodium hydroxide needed to hold the pH of the
reaction mixture constant (e.g. Hall and Lucas continuous titra¬
tion or pH Stat method); or the amount of substrate (e.g., ACh,.
BzCh (benzoylcholine), BuCh) hydrolyzed. Reporting ChE activity
in terms of micromoles of substrate hydrolyzed per ml per minute
makes comparisons more valuable (Cornish, 1971). Analysis of ChE
following   inhibition  by carbamates   requires  special  methods.
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since  the  complexes  formed  with ChEs  by  all   but   a   few  of   the
carbamates are  readily dissociable by dilution   (Wills,  1972).
As previously mentioned, it is important that ChE activity
be assayed frequently to detect peak inhibition during chronic
studies of ChE-I by pesticides. Different pesticides reach peak
ChE-I at different times in different species. Also, a lack of
ChE-I should not be considered as a true absence of effect when
ChE is measured at only one site (e.g., plasma). For example
Cornish (1971) cites a study with guthion in which brain ChE
activity was inhibited by 60% while serum ChE was unaffected.
Measuring only serum ChE would have resulted in a serious under¬
estimation of the risk posed by guthion. Brain and blood contain
both AChE and BuChE, so it is recommended that activities be
determined separately. Reporting activities in terms of percent
of mean control activity, while permitting comparisons between
levels, does not provide information on the pre-exposure condi¬
tion of the animal nor the variability involved. Even in studies
using laboratory animals, where one would expect little varia¬
tion, considerable variation may be present (e.g., see figures
III 1-4). Gage (1967) has pointed out the limitations of com¬
paring individual ChE activities to a population average since
the coefficients of variation in control studies range from 10 to
25 percent. A much better control is a series of pre-exposure
levels on the individual or animal to be studied. Reporting the
variability encountered in a study provides more flexibility in
the choice of dose-response assessment methods (see Section III
of   this   report).
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Table III-l Review of Proposed Dncertainty Factors (OF)
10
10
Proposed by
NAS (1977)
EPA (1986)
10
100
EPA
(Federal
Register, 1981)
NAS (1977)
100 EPA (1986)
100 FDA
(Dourson
and Stara,
1983)
Applicability
Valid experimental data from studies on
prolonged ingestion by man and when there
is no evidence of carcinogenicity.
As above, except generalized to "prolongedexposure," (not just ingestion) and
specified "average healthy humans." Thisfactor is intended to account for the
variation in sensitivity among the membersof the human population.
NOEL values based on ChE-I for organo-
phosphorus and carbamate pesticides.
Cases where data on prolonged human studies
are not available or are scanty (e.g. only
acute exposures), where valid results on
long term animal feeding studies are
available with several species, and where
there is no evidence of carcinogenicity.
As above, except generalized to exposures
other than feeding/ingestion. This factor(10 X 10) is intended to account for the
uncertainty in extrapolating animal data tothe case of humans (lOx^ and for the
variation in sensitivity among humans (lOx).
OR
LOAEL instead of a NOAEL from valid
experimental results from studies using
prolonged exposure to average healthyhumans.
Data from chronic animal studies.  This
factor is intended to account for intra-
(human) and inter-(animal to human)
species variability, and intrastrain vari¬
ability in response to the toxicity of a
chemical, allowance for sensitive human sub-
populations due to illness as compared tohealthy experimental animals, (as above), as
well as possible synergistic action of any oneof the many intentional or unintentional foodadditives or contaminants in the human diet.
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100
100
FAO/WHO
(1962, 1973
in Dourson
and Stara,
1983)
WHO Expert
Comm. for
Pesticide
Residues
(Dourson and
Stara, 1983)
To account for differences in body size of
the laboratory animal vs. man, and
differences in food requirements varying
with age, sex, muscular expenditure, and
environmental conditions, differences in
water balance of exchange between the body
and its environment, differences in hormonal
functions and how they modify food intake,
and differences in susceptibility among
species.  Establishes an "unconditional"
ADI.  ("Conditional" ADIs employ UFs > 100due to uncertainties in animal data or in
regard to the purity of the test substance).
To account for differences in susceptibility
between animals and humans, variations in
human sensitivities, small sample size,
difficulties in estimating human intake, and
the possibility of synergistic action amongchemicals
1000   NAS (1977)
EPA (1986)
Cases where there are no long-term or acute
human data, where animal data are scanty,and where there is no indication of
carcinogenicity.
Cases when extrapolating from less than
chronic results on experimental animals when
there are no useful long-term human data.
This factor (100x10) is intended to account
for the uncertainties cited with use of the
lOOx factor, as well as the uncertainty in
extrapolating from less than chronic NOAELsto chronic NOAELs (lOx) .
OR
1000   FDA
(Dourson and
Stara, 1983)
2 ,000 FDA
(Dourson
and Stara,
1983)
Cases when using a LOAEL instead of a NOAEL
from valid chronic animal studies where data
on long-term human exposures are not
available or are inadequate.
Cases when extrapolating from subchronic
animal NOELs or NOAELs, where data is
available from two species.
As above, except where data are available
for only one species.
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10,000  EPA (1986)     Apply when extrapolating from less than
chronic results in experimental animals when
there are no useful long-term human data,
and where using a LOAEL instead of a NOAEL.
additional
1-lOx  EPA (1986)     Use professional judgment to determine this
additional UF, depending on other aspects of
the study not explicitly treated above;
e.g., number of species tested and the slope
of the dose-response curve.  The default
value for this UF, called the modifying
factor (MF), is one.
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Table III-2:   Ratio of NOELs Implying Interspecies Variability ofChE-I*
Pesticide    Species    Subchronic Study^ Chronic Study^Compared   Plasma  RBC   Brain     Plasma   RBC   Brain
Rat
Parathion     -----  20.4    20.4  ---       22.5^  --   225.0^
Dog
Rat -Malathion     ----   --     21.7° ---
Human
Rat
Chlorthiophos  ----   21      4    11.9      0.4°   3.2°
Dog
Metasystox    (Studies deficient)
Rat
Ethion        ----    6     ---  --
Dog
Rat
Chlorpyrifos  -----   1.9®   1.9® ---
Monkey
Rat
---- 10      1     1
Dog
Mouse
Carbofuran    ----- 3      3     3
Rat
Mouse
Dog
* Comparisons   should   be   interpreted   cautiously,   since   methodology(other  than  length of study)  may be different between comparedstudies.     See  Appendix   III-3.
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Pesticide Species
Compared
Dimethoate
Rat
Dog
Rat
Human
Aldicarb
sulfoxide
Dog
Rat
Subchronic Study
Plasma  RBC  Brain
Chronic Study
Plasma  RBC  Brain
3.2
3.59  -
22'
a
c
d
e
f
g
h
Subchronic  studies are 90 day feeding studies unlessotherwise noted.
Chronic studies are 2 year feeding studies unless otherwisenoted.
Duration of dog study is one year, rat study is 2 years.Duration of human study is 47 days, rat study is 33 days.
Doses in monkey study administered by gavage.
Duration of both studies are 6 months.
Dose in rat study administered by intraperitoneal injection."It does not appear that the doses were established" in rat
study,  and plasma ChE-I was measured in dog study after 1month, although it was a 3 month study.
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Table III-3:   Ratio of NOEL'S Implying Interspecies Variability
of ChE-I, from Edson (1964) Data*
Pesticide Species  Study
Compared Length
(days)
RBC Plasma Considerations
Schradan
pig
rat
pig
human
102
37
5a,b
(1,25)C
pig      102     8
rat   up to 273
(10)'
102
44
1.4
Rats dosed by
intraperitoneal
injection.  Only 2
female pigs/dqse
group.
Only 2 female
pigs/dose group.
Maximum ChE-I at 3rd
week in rat.
Human ChE activity
reported on "whole
blood" basis, but
levels in RBC were
noted to be more
sensitive than plasma;
thus comparison is for
RBC. Dose considered
as human NOEL by Edson
caused 25% ChE-I.
Human doses reported
in mg; individual body
weights not given, but
average body weight
inferred as 70 kg.
human    44
----------------  (1.1)
rat  up to 273
' ͣ't See above.
Dimefox
pig     133     2.4
rat   up to 287
(4)b
(1.6,.1)^
Only 2 female pigs/
dose group. All rats
female. ChE-I reached
a maximum after 4
weeks for both
species. Variable
dosing schedule for
pig.
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Pesticide Species  Study
Compared Length
(days)
RBC Plasma Considerations
(Dimefox)
pig
human
133
70
rat
human
pig
Parathion ----
rat
up to 287
70
up to 122
84
1.5
48 960^
pig
human
up to 122  24
up to 70
480
Same as pig/rat,
dimefox and pig/human,
schradan considerations
(above), except human
doses reported on mg/kg
basis.
See above.
Dose considered as rat
NOEL by Edson caused 54%
ChE-I.  (RBC ratio is
480 if consider this
dose the LOEL.)  Maximum
ChE-I at 4th week in
rats and 6th week in
pigs.  Variable dosing
schedule in pig.
Variable dosing
schedules in human and
pig.  Human doses
reported in rag;
individual body weights
not given but average
body weight inferred to
be 68 kg. Doses
multiplied by 5/7 since
given 5 days/week. As
above, measured in whole
blood, but this time
levels in plasma were
noted to be more
sensitive (LOEL caused
16% RBC ChE-I and 37%
plasma ChE-I). Only 2
female pigs/dose group.
Maximum ChE-I at 7th
week in humans and 6th
week in pigs.
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Pesticide Species Study    RBC   Plasma     ConsiderationsCompared Length
(days) ' '_________
human  up to 70   20^  --       Same as above.Parathion ----  -------   (2°)
rat     84
*   Determined in feeding/oral studies unless otherwise noted
^   Ratio obtained by considering dose(s) described as causing"slight"  ChE-I as LOEL(s)  (i.e.,  "slight" ChE-I  isconsidered an effect).
"   Ratio obtained by considering dose{s) described as causing"slight" ChE-I as NOEL{s)  (i.e.,  "slight" ChE is notconsidered an effect).
^   Ratio obtained by considering dose(s) described as causing"slight"  ChE-I as a NOEL in one species and a LOEL in theother species.
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Table III-4;   Examples of Species Differences in Netcibolism
of ChE-Inhibiting Pesticides*
Pesticide
Species
Compared
Factor
Measured
Interspecies
Variation
malathion
parathion
carbaryl
malaoxon
malaoxon
malaoxon
malaoxon
paraoxon
paraoxon
paraoxon
human
rat(male)
rat(male)
human
rat(male)
human
rat(male)
human(male)
dog(male)
human(male)
human(female)
human(male)
cat(male)
human(male)
rat(male)
human(male)
dog(male)
human(male)
human(male)
human(female)
rate of metabolism
(% degraded in liver
homogenate/h/20mg)
percentage hydrolyzed
(based on AChE-I) after
incubation of pesticide
with sera
14.0
7.1
99.8
98
63.1
14.8
61 ±9
1 ±2
=  61
6 ±2
1 ±2
5 ±2
1 ±2
IOC1 ±0
1 ±2
32 ±7
22 ±4
= 100
94 ±4
22 ±4
22 ±4
13 ±7
From Calabrese(1983) and Hollingworth (1971)
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Pesticide
Species
Compared
Factor
Measured
Interspecies
Variation
paraoxon
rat(male)
human
ͣ50 (concentration
required to effect a 50%
reduction) for plasma
ChE (10~^M)
1.8
1.1
paraoxon
paraoxon
human
dog
pig
human
0.3
7.9
1.1
III T-10
EXPLANATION OF FIGURES
Figures III-l through III-4 are plots of the data given in
Appendix III-2, Table 2, of mean activities (± standard devia¬
tion) of plasma, erythrocyte (RBC) and brain cholinesterase in
dogs fed parathion for one year. Activities are shown after two,
four   and  twelve  months  for males  and  famales.
Figure  III-l:     RBC   and   Brain  ChE   in  Male  Dogs
Figure  III-2:     RBC  and  Brain ChE  in Female Dogs
Figure  III-3:     Plasma ChE  in Male Dogs
Figure  III-4:     Plasma ChE  in Female Dogs
Figures  III-5   through  III-IO  are  semi-log  plots  of  the  same
data  described  above   (not  brain  ChE).
Figure  III-5:     RBC and Plasma ChE in Males  (measured at 12months)
Figure III-6:     RBC and Plasma ChE  in Females   (measured at 12
months)
Figure III-7:     RBC  and  Plasma ChE  in  Males   (measured at  4months)
Figure  III-8:     RBC   and   Plasma  ChE  in  Females   (measured  at4  months)
Figure III-9:     RBC  and  Plasma ChE   in  Males   (measured  at  2months)
Figure  III-IO:   RBC   and   Plasma  ChE  in Females   (measured  at2   months)
Figure   III-ll   is  a   semi-log  plot  of  the  data  given   in
Appendix   III-2,   Table   1   of  mean   activities   (as   percent   of
control)  of plasma and RBC cholinesterase in rats fed parathion
for  two years.     Activities  are  shown  at  termination   (26  months
for  males  and 28 months  for  females).
Ill F-1
300%
2500
2000
1500 ..
1000 ͣ
500
Figure   iri-li     'lean Activity  (lu/nl)   of RBC  Cholinesterase   inMale  Dogs  Fed Parathion for One  Year     (Pleasured at 2,  4,and  12 -lonths)
3ars indicate - s.d.
(2  lonths)
(   ^ months]
;(12 Tiionths)
"lean Activity  (lU/ral)   of Brain Cholinesterase   in "laleDogs Fed Parathion for One  Year     (Measured at  12 months only)
0.01 0.03
Dose   (nig/kg/d) 0.10
3000,
Figure   Iir-2i     "lean Activity  (lU/nil)   of  R5C  Cholinesterase   inFemale   Dogs  Fed  Parathion  for  One  Year     ("Measured  at2,  k,  and  12 months,'
Bars   indicate   -  s.d,
2500
2000
1500--
(2  T.onths)
(12  months)
(k months)
Mean Activity  (lU/ml)   of Brain Cholinesterase   in Female  Dogs FedParathion for One Year ( feasured at  12  months only)
1000.
0 0.01 0:03
0.10
Dose   (mg/kg/dj
Figure   III-31
1000
0.01
Mean Activity   (lU/ml)   of  Plasma Gholinesterase
in  'lale  Dogs  Fed Parathion  for  One  Year
(Measured at 2.4  and   12  -nonths)
3ars indicate -
30001
( ͣnonth   2)
(month 4)
(month   12;
0.03 0.10
Dose   (rag/kg/d)
Figure   Ill-i+i     Mean Activity   (lU/ml)   of  Plasma Cholinesterase
in Female  Dogs  Fed  Parathion  for  One   Year     (Measured  at
2,k,   and   12  months)
3ars indicate +/- s.d.
2500
200
L
ISOCfcf
10004
(2  months)
[^ months)
(12 months)
0.01 0.03
Dose   (mg/kg/d)
0.10
3000
2400
1800
Figure III-5
rnr^r
tnc.  iam XL? months
I
PiasTia,   Hale   (12  months J
1200
; boo
0.01 Dose   (mg/kg/d) 0.03
01 '0 ____e.oio.
(p/Sjl/Sui)   asoa
lOJO
009
0021
0081-
OOt/t
000C
(gqxuool zx)   ^x'Bwad fBuieBtd
zxy-yftowei 'onnJfUlWMH
g-III   aanstj
i»
>
ͣH
O
<
Figure   III-7
RiiG ,  "4ale   (4 month
(4  months)Plasma,  'Wale
12300
?200
2000
1800
loOO
0^-et
Dose   (mg/kg/d)
0.03
-T-41400
O'.IO
Figure   III-8
PC,   Female   (4 ponthp)      I
Plasma,"Female   [i* months)
~r2500
-41900
Dose   (mg/kg/d) °'°^
noo
0.10
Figure III-9
I . ,  , , .  .  . . I ;
Plasma .'Male (2 months)
2400
2200
2000
1800
0,01
Dose (mg/kg/d) 0.03
1500
0.10
Figure  III-IO
0. or
Dose   (mg/kg/d)
0.03
i-^XPP'^1'
I    ͣ      I
2200
2100
!000
:::;-j;Pljas.-na,   B'emaie'(2 mvnthsi)
ͣ] ->„
'1900
RUG,   Fe-n:|Lle   (i? montbs)
!l800
0.10
340-L3ID     DIET7I3FN     nRAPH    CAPFTR
SFMI-LD'   Adi TMMrC
CYCLFS X  in rH\'ic:ini.jr; pfr ini^h
OrrTZRFM    CDRPORAnnN
Pipure   III-ll:      lean Cholinesterase  Activity   in  Rats  Fed  Parathion   (^ea!=;urod   at 2'S   -  28 -nonths)
!» Ul        01       sj     {D     © fc Ul       01       si     (P     (D   0
SI
01
(«
a)
ͣp
M
lU
c
D
ͣU
f
D
a
c
+^
c;
0)
ͣ^ema
Plasi-na,   '4l4lo   ( i )
jO.O
Dose   (ppm)
Appendix III-l:  Approaches to Dose Response Assessment ofParathion
1.   NOEL-DF Approach
A. Current EPA ADI
Current ADI of 0.005 mg/kg/day was set at the 1965
Joint Meeting of the FAO Committee on Pesticides in Agri¬
culture and the WHO Expert Committee on Pesticide Residue.
"It appears ... that this level has been established on the
basis of a "NOEL" of 1.0 ppm or 0.05 mg/kg/day, for ChE-I,
generated from a long-term feeding study in the rat, using a
lOX safety factor. BSi. data evaluation j:£Cord.a ^i£ SlUsJ.!-
SiillOu. and no reference has been made to this study in the
Toxicology Branch files. Thus the y^lidii^ of the study
could not h£.  determined." [emphasis added] (Ghali, 1985)
B. ADI Using Most Sensitive Species
Can not be determined since NOEL was less than 0.4 ppm
(less than 0.01 mg/kg/day). Data is from chronic feeding
study in dogs (Pharmacopatics Res. Inc., Report No. 7828,
8/20/81) .
C. ADI Using Most Sensitive Species for which a NOEL was
Observed
Using a 2 year feeding study in rats (Biodynamics, Inc.
Report No. BD78-0005, 1/23/84), [data given in Appendix III-
NOEL = O.Sppm = 0.25mg/kg/day
based on ChE-I significantly different from con¬
trol value (p < 0.05) at next highest dose (5ppm).
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This occurred in pl^fim^ ChE of females at 12
months (but not other times measured) and in RBC
(at 6 and 12 months) and plasma (at 18 months) in
males (measured ChE at 6, 12, 18 months and at
termination)
Uncertainty Factor Choices and Resultant ADIs:
1. lOx (based on EPA OPP) = 0.0025 mg/kg/d
2. lOOx (based on NAS,EPA,FDA,FAO/WHO, WHO) =
0.0025 mg/kg/d
2.   BD-DF Approach
A.   ADI Using Most Sensitive Species*
The model y = /6„+/3, (In dose) for dose > 0 was fitted
to the data in Appendix III-2 to obtain the BD, defined here
as the dose causing a 10% inhibition of ChE. This model was
chosen for its simplicity and because the data fit a
straight line when log dose was plotted against either
plasma or RBC ChE activity (lU/ml) for each time period
measured (Figures III-5 to III-IO). Such log dose plots
are common in toxicology (Doull, 1980). Other data of ChB-I
by parathion supported this model (Figure III-ll). The main
disadvantage to this model is that it can not directly
accomodate the response at a zero dose (since ln(0) is
undefined) ,  and  it must be  assumed  that  the dose-response
*
Since this was also the only data set for which standarderrors were available, it was the only data set to which theBD-UF  approach could be applied.
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relationship remains linear to the BD. However, the control
response value is indirectly incorporated in the estimation
of the confidence limits around the response at the BD.
Using the data on male beagle dogs fed parathion
(plasma ChE measured after 12 months of feeding), the esti¬
mated dose causing a 10% inhibition of plasma ChE (ED^q) is
4.1 X 10" -^, The 95% upper and lower confidence limits are
3.7x10"^ and l.lxlO"^. According to Crump the BD is the
statistical lower confidence limit to EDgQ, or 1.1x10" . To
determine a RfD, an UF must be applied.
3.   Linear Extrapolation
A.  ADI Using Most Sensitive Species*
Using the same data on plasma GhE-I measured at the
12th month for beagle dogs fed parathion, the EDgQ was
calculated (from 2A) as 4.2x10 -'. The upper confidence
limit on the amount of plasma ChE-I associated with this
dose is U=43.5. If it is desired to control the response to
5% ChE-I (R = 0.05) compared to controls, then an UF = U/R
= 43.5/0.05 = 870 is required. The RFD would then be
4.2xl0"-^/870 = 4.8x10"^, based on plasma ChE-I measured at
twelve months in male beagle dogs. Determining an EDgQ or
EDyQ and using R = .10 or .20 would result in an RfD closer
to that obtained by the NOEL-UF method.
Since this was also the only data set for which standarderrors were available, it was the only data set that linearextrapolation could be applied.
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Following are EDgg's and RfD's for plasma and RBC ChE-I
measured at two, four, and twelve months for males and
female beagle dogs   (based on R =   .05,   as  above):
Characteristics
(Sex,   site,   time
ChE-l measured)
ED 90
Male, plasma, 12
Male, plasma, 2
Male, plasma, 2
Female, plasma 12
Female, plasma, 4
Female, plasma, 2
Male, RBC, 12
Male, RBC, 4
Male, RBC, 2
Female, RBC, 12
Female, RBC, 4
Female, RBC, 2
Confidence
Limits (95%)
for ED 90
D=Opper
Confidence
Limit on
Response
at ED90
4.2x10"^
2.9xl0"2
3.5xl0"3
8.6x10"^
1.5xl0~2
1.7x10""^
3.0xl0"3
2.5x10"?
2.0xl0"3
3.2x10"^
1.2xl0"2
1.9xl0"3
(1.1x10
(7.0x10
(4.2x10
(4.7x10
(9.3x10
(10,
(1.1x10
(2.6x10
(2.8x10
(3.1x10'
(1.4x10'
(1.3x10'
-4
-3' 3.7x10-2^, 8.1x10"?
I,   7.5xl0"2
"J, 5.2xl0"2"^, 7.9xl0"2
9.4X10"-'-
2.4xl0"2
1.9x10"^)
r   4.0x10-1)
°, 7.5xl0"2)
f^ 4.8xl0~2j
^^,   2.7xl0"l)
-4
ͣ4'
ͣ1§
43.5
68.4
50.8
48.3
62.5
66.7
56.9
51.7
50.5
66.9
49.0
DF=D/R
870
1368
1016
966
1252
1334
1138
1034
1010
1338
980
ͣRfD"=
EDgg/DF
4.8x10"^
2.1xl0"5
3.4x10"^
8.9x10"^
1.2xl0"5
2.2x10"^
2.2xl0"5
1.9x10"^
3.2xl6"6
9.0xl0"f1.9x10"^
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Appendix  III-2i     Data on ChE-I  by Parathion
TABLE 1-    Mean Choiinesterase Activity In Rats Fed Parathlon (Percent of Control)
Dose Level 6 Months 12 Months 18 Months Termination^____(ppm) Plasma      RBC      Plasma        RBC      Plasma        R8C      Plasma        R8C      Brain
Males
0.5 100 100 90 95 78 100 94 109 103
5.0 71 87** 80 86* 41* 94 63 102 92
50.0 14** 91** 10** 88 7** 100 6** 95 22**
Females
0.5 103 101 91 97 100 98 J19 96 96
5.0 82 97 63* 90 64 91 81 87 98
50.0 11** 91 6** 86* 8** 88 13** 88 18**
*Significantly different from control  value at p < 0.05.
''*Significantly different from control value at p < 0.01.
^ Terminal sacrifice was at 26 months for males and 28 months for females.
Citation:     Daly,   I.     (1984).     2thyl parathion chronic  feeding study.Report No.   77-2055  prepared by Biodynamics,   Inc.   for .Monsanto Company.January 2J,   1984.    EP.4 Accession No.   252702-705.     In Ghali,   George Z.(1985).     Parathion  Registration Standard,  EPA
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Appendix  III-2«     Data on GhE-I  by Parathion
TABLE 2. Mean Activities of Plasma Erythrocyte and Brain Choiinestarase in DogsFed Ethyl Parathion for One Year
BrainGroup/Oose Plasma cholinesterase (lU/ml) at month  R8C cholinesterase (lU/ml) a+  month   cholines+erase<mg/kg/d) 2 4 12 2 4 12     at month 12
Males
0
0.01
0.03
0.1
2790+385*
(l50)
2071+162
(100)
1665+158
(100)
2634+354
(100)
2346+404
(100)
2699+145
(100)
899+432
(100)
2238+286*
(80)
2250+324
(109)
1218+328*
(73)
2228+208*
(84)
2274+315
(97)
2111+189*
(78)
459+89
(50
2050+458*
(73)
1891+377
(91)
968+173*
(68)
2188+416*
(83)
2122+213
(90)
1904+150*
-(70.5)
662+438
(74)
1667+331*
(60)
1399+208*
(67)
601+193*
(46)
2031+275*
(77)
1718+204*
(73)
1558+198*
(58)
586+70
(65)
Females
0
0.01
0.03
0.1
2567+184
(100)
2064+231
(100)
1735+219
(100)
2552+255
(100)
2643+287
(100)
2654+238
(lOO)
545+124
(100)
1924+211*
(75)
1965+255
(95)
1470+380
(85)
2136+276*
(83)
2407+199
(90
2272+407*
(86)
728+216
(134)
2041+376*
(79)
1663+386*
(80
1184+208*
(68)
1947+369*
(76)
2019+259*
(76)
1848+134*
(70)
347+134*
(64)
1856+173*
(72)
1353+231*
(64)
763+212*
(34)
1882+219*
(74)
1585+269*
(60)
1665+286*
(63)
545+97
(100)
Mean value and deviation; the values in paratheses are cholinesterase activities expressed as percent ofcontroI.
Significantly different from control value at p<0.05 (Dunnetts' test).
Citation I     Ahmed,  F.   5.,   Sagartz,   J.W.,   Tegeris,   A.   3.,  et al.     One yearfeeding study in dogs.     (Unpublished Study No.   PRL-77-115 prepared byPhanacopathics Research Laboratories,   Inc.,   Laurel,   '.id,   for ^Tonsanto Co.,St.   Louis,   ^10;   dated August  20,   1981.)     Accession Nos.   246639,   246642-43.In Ghali,   George  Z.   (1985).     Parathion  Registration Standard,  EPA
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Appendix  III-3: Data   on   Cholinesterase   Inhibition   byPesticides
Data from EPA's "Caswell files" in the Office of Pesticide
Programs (OPP) were reviewed for the following pesticides: para-
thion, malathion, aldicarb, chlorthiophos, chlorpyrifos,
dimethoate, ethion, metasystox, and carbofuran. These pesticides
were selected since all have been tested in humans. The quality
of the available data for metasystox was too poor to use for
further analysis. The following information was abstracted for
each study: study type and length (e.g., one year feeding),
species, ChE NOEL in plasma, RBC, and brain (if measured),
administration of dose (e.g., solution dissolved in 25 ml corn
oil), method of ChE measurement (e.g., Michel's potentiometric),
purity/grade of pesticide, time of measurement of ChE, number
(age) of subjects, doses tested, and other pertinent information
(e.g., study conducted by IBT; reevaluation pending). Informa¬
tion  on method of ChE measurement was  frequently not  reported.
The reviews described above are too lengthy to be included
here, but the original worksheets and typed summaries prepared by
EPA's Risk Assessment Forum    are available from the author.
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IV.  Exposure Assessment
EPA's general approach and framework for conducting exposure
assessments is outlined in its "Proposed Guidelines for Exposure
Assessment" (Federal Register, 1984). Exposure assessments
generally cover five principal topics: (1) sources, (2) exposure
pathways and environmental fate, (3) monitored or estimated con¬
centration levels, (4) exposed populations, and (5) integrated
exposure analysis (combines (3) and (4) to give exposure pro¬
files). Since an exposure assessment is part of the overall risk
assessment, it should be coordinated with the findings of the
previous two steps of the risk assessment. For ChE-I pesticides,
this means that both acute and chronic exposure scenarios and
oral, dermal, and inhalation routes of exposure should be con¬
sidered. (Although this review has focused on oral toxicity, the
most common route of exposure for the general public, most ChE-I
pesticides are readily absorbed through the skin and lung and can
pose a hazard through these routes of exposure as well.)
ChE-I pesticides have a wide variety of uses, so that
exposures may occur in a variety of ways (Blum and Manzo, 1985),
Some ChE-I insecticides are systemic (i.e. absorbed and distri¬
buted throughout plants) and can be ingested either in their
original form or as a breakdown product when the plant is in¬
gested. Malathion, parathion, and diazinon are examples of
systemic insecticides. Other ChE-I pesticides (e.g. fen-
chlorphos) are used to control parasites of domestic animals, and
may be given orally or dermally. Nematocides (e.g. prophos,
zinophos) are introduced into the soil through the water system.
Other ChE-I pesticides are used as fungicides (e.g. edinphos,
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phosbutyl), herbicides (e.g., bensulide), rodenticides (e.g.
gophocide), insect repel lants (e.g. o-n-butyl-o-cyclohexenyl-N,
N-diethylphosphoramidate) , and insecticide synergists (e.g.
propyl-2-propynylphenylphosphonate)   (Blum and  Manzo,   1985).
Both agricultural and non-agricultural uses of ChE-I pesti¬
cides are significant. Of the thirty million pounds of insecti¬
cides used on corn in 1982, 95% (28.4 million) were either OPs or
carbamates. Almost half of the insecticides used in 1982 on
thirteen major field and forage crops in thirty-three states were
used on corn. Another 1.5 million pounds of parathion was used
on wheat (Marquis, 1986). Four of the top ten pesticides used by
homeowners were ChE-I pesticides, according to EPA (GAO, 1986).
These include diazinon, chlorpyrifos, carbaryl and malathion.
These four are also among the top twenty-five pesticides used by
professional applicators for nonagricultural purposes, according
to the 1984 National Urban Pesticide Applicators Survey (NUPAS).
Parathion was  ranked  as  thirty-third.   (GAO,   1986).
A   recent   GAO   report   (1986)   points   out   why  non-agricultural
uses of pesticides are of particular concern:
o There is no approach for controlling exposures result¬ing from the use of nonagricultural products that iscomparable to the tolerance setting process for agri¬cultural pesticides. The potential for cumulativeexposure is generally not determined when a non-agricultural pesticide product is considered forregistration  by  EPA.
o People who apply pesticides around their homes, or hireothers to do so, are poorly informed about the risksassociated with pesticide use. Information containedon pesticide labels is limited, and information pro¬vided in advertisements or literature from manufac¬turers, distributors or professional applicators is atbest   limited,   and   frequently  unlawful.     Rarely do   any
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of these sources available to the homeowner discuss
chronic health effects or gaps in the database.
o People may be exposed to non-agricultural pesticides inpublic places (e.g. schools, offices, hotels,restaurants) without their knowledge or against theirwill. This is of particular concern to people who arehypersensitive to chemicals.
o Some professional applicators, particularly those thatapply pesticides only to their employers' properties(known as "not for hire" applicators) are not requiredto be tested to ensure that they are competent to applypesticides. ^
In addition, many persons identified as potentially highly
susceptible to ChE-I pesticides may spend much of their time at
home, or other public places where nonagricultural pesticides
might be used. For example, infants, children, pregnant women
and their unborn children, and ill persons may spend much of
their time at home.
As with nonagricultural uses, agricultural uses of ChE-I
pesticides can result in occupational exposures and exposures to
the general public (primarily through food and water). Occupa¬
tional exposures may be estimated by direct or indirect
approaches. Direct methods sample pesticides as the workers
encounter them, by estimating the amount that could contact the
skin or be inhaled. Indirect methods measure the pesticide or
its metabolites in human fluids or via some other indicator of
physiological effect (Hayes, Wise and Weir, 1980).
The measurement of ChE-I in blood has been frequently used
an an indirect method of estimating exposure of workers to ChE-I
pesticides. However, as Wills (1972) points out, the finding of
a normal ChE activity in a worker suspected of receiving exposure
to ChE-I pesticides does not necessarily mean that no exposure
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has occurred, because some ChE-I pesticides have little effect on
blood ChE (even in doses near the lethal dose), and because
regeneration of blood ChE's (particularly BuCh) may be rapid
enough so that ChE activity in the blood is within normal limits
despite significant inhibition within some neuroeffector systems.
Also, some workers may have low ChE activities due to genetic or
nutritional factors. The Subcommittee on Pesticides of the
Permanent Commission and International Association on Occu¬
pational Health recommended in 1976 that other biological methods
(e.g. electromyograms, or EMGs) be investigated to assess expo¬
sure   in   addition   to  ChE-I   (Zavon,   1976).
A number of researchers [e.g. Gage (1967), Cornish (1971),
Zavon (1976), Vandekar (1980)] have suggested levels of ChE-I
which could be considered indicative of unsatisfactory occupa¬
tional exposures. These range from twenty to fifty percent ChE-
I. In an attempt to answer the question, "What level of ChE-I
should be considered to be of regulatory significance?", many EPA
reviewers have argued that these levels should be considered as
estimates of a biological threshold, and used to define the cut¬
off for a NOEL. It should be remembered, however, that these
figures were originally developed to apply to healthy adult
(usually male) workers, and probably do not apply to others in
the general population. Gage (1967) clearly shows the intended
purpose of these levels: "The method [i.e., of using a threshold
limit of ChE-I to 'indicate the existence of unsatisfactory
working conditions'] would fall into disrepute if men were too
frequently taken off work or if there were an interruption of
production  or  of  application  processes  when  no clinical   symptoms
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were apparent, nor any evidence of a breakdown in safety pre¬
cautions." While 20-50% ChE-I may be an acceptable level of ChE-
I for healthy adult workers who voluntarily work in areas where
exposures are known to occur, it should not be misinterpreted as
a population threshold (defined as the lowest of the thresholds
of the individuals within a population (EPA, 1986)).
In addition to indirect and direct approaches to monitoring
exposure, models may also be used to estimate exposures. For
example, Guy, Hadgraft and Maibach (1985) developed a kinetic
model of chemical absorption via human skin which they applied to
the study of percutaneous absorption of malathion.
Potential exposures to the general public through the diet
can be estimated using EPA's Tolerance Assessment System (TAS).
The TAS can be used to estimate the distribution of exposure to a
pesticide among individuals who eat a particular food commodity.
A pesticide tolerance is the maximum permissible concentration of
a pesticide allowed in or on raw agricultural commodities and
processed foods. The TAS can (and should) be used to ensure that
infants, children and others do not face high dietary risks from
ChE-I pesticides. Vegetarians and others eating large quantities
of fruits and vegetables have been known to exhibit chronic mild
anti-ChE poisoning (Ratner et al., 1983).
The size, distribution, and other characteristics of the
subpopulations of high sensitivity should be studied. In con¬
trast to some highly sensitive subgroups (e.g., children), those
possessing non-typical serum ChE activities are not readily
identifiable.  Different races appear to have different
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frequencies of the non-typical ChE's. According to Silver
(1974), Caucasian populations investigated from Canada, U.S., and
various European countries, as well as Australian aborigines,
generally comprise about three to four percent heterozygotes
possessing both the normal and atypical variant (i.e., E^^E]^^).
The atypical variant is absent or very rare in the population of
Tristan de Cunha, certain of the Eskimo and Red Indian tribes,
Icelanders, American and African blacks, Japanese, and other
Oriental populations. Other nontypical variants are more rare
(less than one percent). According to Udsin (1970) an Israeli
population studied had a high frequency of the E^^ phenotype.
The frequency of heterozygotes in Israel varies from 0.7% among
North African Jews to 3.1% among European Ashkenazi Jews to 9.7%
among Jews from Iraq and Iran. Udsin also reported that a popu¬
lation of southern Eskimos studied had a high incidence of
atypical (E^^) homozygotes, heterozygotes, and "silent" gene
individuals.
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V.   Risk Characterization
A.   Uncertainty
In this, the final stage of the risk assessment, information
about the hazard of the substance and the potential for human
exposure from the last three stages is combined to estimate the
extent of public health risk. The dose-response data and assess¬
ment approach chosen is discussed, as is the data describing the
population groups for which exposure estimates are most meaning¬
ful. Perhaps most important, the uncertainties in characterizing
the risk are presented and their implications discussed.
Presenting the uncertainties and the corresponding
assumptions and judgments made to deal with those uncertainties
is crucial since:
1) this makes it easier to go back and revise the risk
estimate if this is necessitated by new data or
research clarifying the uncertainty
2) it influences decisions made by the risk manager.
Classifying uncertainties helps to structure the presenta¬
tion and thus increases the risk manager's efficiency in using
this information to make decisions. One such classification
scheme is that adapted from McGarity's (1979) discussion of the
types of science policy issues involved in regulating carcinogens
by EPA (and OSHA). His discussion is applicable to science
policy issues associated with the regulation of other hazardous
substances, including ChE-inhibiting pesticides. These science
policy issues originate from uncertainties that are associated
with the risk assessment procedure. McGarity's categorization
contains four types of science policy issues, which really lie on
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a continuum between issues of pure scientific fact and pure
policy, and which are paralleled by four types of uncertainty
(using  the  same descriptors  as  McGarity):
1) "Trans-scientific" uncertainty — uncertainty which
theoretica]ly could be resolved, but for practical or
moral reasons, can not be. For example, one could
demonstrate with a high degree of accuracy the shape of
the dose-response curve for persons exposed to ChE-
inhibiting pesticides by using hundreds of volunteers
at scores of dosage levels, but this would not be
practical  or  ethical.
2) Uncertainty due to insufficient data — uncertainty
which could be resolved if more time and resources were
spent. For example, more data is needed to understand
how individuals with genetically non-typical ChE
respond   to ChE-inhibiting  pesticides.
3) Uncertainty resulting from varying scientific interpre¬
tation -- For example, some EPA scientists (and
scientists in the research community) interpret the
NOEL from the same study of ChE-inhibiting pesticides
differently. Some feel that 20% inhibition of RBC or
plasma ChE compared to control values should be consid¬
ered a response, whereas others feel a greater inhibi¬
tion in plasma is necessary. Some feel that a statis¬
tical measure of significance should be used,   rather
*
The   term   "transscientific"   was   coined   by  Alvin  Weinb urg(1972)   in  "Science and Trans  Science,"  Minerva      10:  209
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than an absolute percent inhibition.  Others feel that
the inhibition should only be compared to pre-exposure
values of ChE in the same animal rather than to values
in the control group.
4)   Uncertainty resulting from disagreement over inferences
— This category encompasses many of the uncertainties
in using animals as models for dose-response assessment
in humans, and of using a non-random sample of humans
as predictors for the population at large.
Questions relating to the amount society should pay for
protection from risks associated with these compounds, or the
extent to which regulatory approaches should protect sensitive
subpopulations, involve political, legal, ethical and economic
uncertainties associated with risk management, which lie outside
the scope of this paper.
McGarity's classification of uncertainty is useful since it
simplifies both the analysis of uncertainty and the science
policy decisions for describing, expressing and/or resolving
uncertainty. McGarity advocates a results-oriented approach to
dealing with these issues in light of the fact that they are not
scientifically resolvable at the time the decision must be made.
This is not to say that factual accuracy or scientific reasoning
is disregarded; to the contrary, additional data and more
sophisticated analyses can resolve or at least clarify or narrow
the range of uncertainty. Indeed, a results-oriented approach
should be the outcome of a consistent and rational risk assess¬
ment policy.
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Such a classification scheme also helps the risk manager to
decide what approaches to take for resolving the uncertainty in
the future. For example, additional research to generate more
data would be much more useful for type 2 uncertainties than for
type 3. A better approach for handling type 3 uncertainties
would be activities directed towards consensus building. For
type 1 uncertainties there is a declining rate of return on
investments  to  narrow the  range  of  uncertainty.
Appendix V-1 provides examples of these different types of
uncertainties encountered throughout the risk assessment of ChE-I
pesticides.
With regard to ChE-I per ££, most of the uncertainties
result from differences in interpretation and disagreement over
inferences (type 3 and 4 uncertainties). This is not surprising,
since ChE-I has been known to be associated with OPs and carba¬
mates for a long time, and extensive research has been done in
this area. In contrast, a much larger proportion of the un¬
certainty in regard to neurobehavioral effects is of type 2,
resulting  from  inadequate data.
B.     Summary and Recommendations
In concluding,   let us  re-examine the components that were
originally proposed for analysis in this review:
o        What degree  of ChE-I   is  significant   (i.e.,   to beregarded  as  an   effect)?
The  uncertainties   regarding   the   role  of ChE's   (particularly
in the blood)  and the influence of other factors   (e.g.,   rate of
ChE-I,   degree  of  inhibition of arylesterases,   as well  as  age,
diet,   etc.)   on   the   toxicity  of   ChE-I   pesticides  makes   this   a
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difficult question to answer. Although a large degree of ChE-I
in the blood (e.g., 70%) is usually accompanied by unmistakable
signs of poisoning, the effects associated with smaller levels of
inhibition (particularly those observed with chronic exposures)
are less clear. Since ChE-I is a graded response, with some
inhibition occurring even at very low doses, it is difficult to
determine a level which is considered to be the biological
threshold for an individual. Although levels of ChE-I have been
determined to be "significant" in occupational settings (i.e., if
that level is exceeded the worker is removed from the exposure),
these levels are not necessarily appropriate as estimates of a
threshold for the general population, including sensitive
subgroups.
Several approaches to developing a scientific policy for
this component were presented. Since the determination of a
population threshold for exposures to ChE-I pesticides is a
trans-scientific problem, it is necessary that a level of ChE-I
believed to be adverse be determined as a matter of science
policy. Various considerations in setting such a level (e.g.,
site of ChE, how measured) were given. The choice of dose-
response assessment method influences the importance that this
uncertainty (regarding what level of ChE-I is biologically signi¬
ficant) has on the risk assessment (i.e., this is more important
with  the  NOEL-UF  approach  than  with other  approaches).
o What dose-response assessment methods should beused to extrapolate from experimental doses toexposure doses?
The   advantages   and   disadvantages   of   the   four  principal
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methods were discussed. Although the NOEL-UF. approach has
historically been used, it has several drawbacks, particularly in
that it neglects dose-response information, discourages large
sensitive studies, and can not always be used (e.g., if NOEL is
less than the lowest dose tested). Various options to remedy
these shortcomings were suggested. It is recommended that the
wealth of information on the mechanism of action of ChE-I pesti¬
cides be exploited to develop mathematical models as an alterna¬
tive to the NOEL-UF approach. Registrants should be encouraged
to provide data in which the variability is reported, so that
alternative methods of dose-response assessment can be used. A
risk assessment policy that allows some flexibility in the choice
of dose-response assessment methods will result in a more effi¬
cient use of available data.
o What uncertainty factor should be employed forinterspecies variation of ChE-I between animalsand humans?
Investigating the interspecies variability in an admittedly
small sample indicated that the NOEL in one species was on
average five fold different than in another species (measured at
the same site), and ranged from one to twenty-five in studies of
comparable length. These results should be viewed cum grgpp
sal is since methodological factors in addition to species differ¬
ences may have accounted for the observed variability. The
routes of administration were comparable except where noted. In
an attempt to reduce the variability due to differences in
methodology, studies reported by one researcher (Edson, 1964) of
schradan, dimefox, and parathion in the pig, rat and human were
compared.  Inconsistencies in the reporting of the data also
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render these results debatable.  The interspecies variability
observed for schradan and dimefox was comparable to that reported
above, although the variability for parathion was much greater,
particularly when ChE-I was measured in plasma.
The traditional UF of ten for interspecies variability
appears to be adequate in most cases, but does not fully account
for differences in sensitivity between humans and test animals
for some ChE-I pesticides (e.g., malathion and parathion).
o   What uncertainty factor should be employed forintraspecies variation of ChE-I?
Age was identified as a significant factor affecting intra¬
species variability to ChE-I pesticides. Young cattle and rats
are up to thirty times more sensitive than the adults of their
species. Nutrition and gender also influence intraspecies vari¬
ability. Pregnancy, genetically-determined atypical ChE's and
low activity paraoxonase, and a variety of health conditions are
likely to increase sensitivity to ChE-I pesticides. A variety of
drugs, chemicals and other agents are known to potentiate or
contribute to the toxicity of some ChE-I pesticides.
It is not clear whether the use of the term "intraspecies
variation" in reference to UF's is supposed to account for poten¬
tial exposures to the agents which can potentiate or otherwise
increase toxicity. It is recommended that for those pesticides
where synergism or potentiation by other environmental agents is
likely to occur (e.g., malathion) that an additional MF be
applied.
The traditional UF of ten is not adequate to account for the
increased sensitivities of special subgroups in the general popu-
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lation, particularly infants.  Clearly, EPA's use of an UF as
small as ten (Federal Register, 1981) to account for both inter-
and intraspecies variability is not justified.  Either a larger
UF is required, or a dose-response assessment method which does
not employ inter- and intraspecies variation UF's should be used.
o What special considerations should be included inexposure assessments for ChE-I pesticides?
The size, location and extent of exposure of the potential
subgroups identified should be determined.  Nonagricultural uses
of ChE-I pesticides deserve special attention since exposures may
be involuntary and/or may result in greater exposures to certain
sensitive subgroups (e.g., small children, pregnant women, or ill
persons in the home).
o What are the uncertainties in estimating theextent of health effects associated with these
compounds? How should they be estimated andpresented to Agency decision makers?
Appendix V-1 presents some of the major uncertainties in
assessing the risks of ChE-I pesticides. It is recommended that
uncertainties be presented in an organized format according to
McGarity's classification of type of uncertainty. This enables
the decision maker to quickly ascertain the nature of the un¬
certainties and what to do about them. Information bearing on a
particular uncertainty is more likely to be utilized when
uncertainties are explicitly identified in this way.
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Appendix V-1:
Type* Pncertainty
Examples of Dncertainty in the Risk Assessmentof ChE-I Pesticides
Egplanation
Hazard Identification
What is the role of ChE
in RBC's?  In plasma?
What amount of ChE-I in
blood is an adverse
effect?
How should the rate
of ChE-I be used to
establish an adverse
effect?
Does a study have
special characteristics
that lead one to question
its results?
If so, how should the
results of that study
be interpreted?
2 Does the change in ChE
activity associated with
a variety of conditions
(e.g., pregnancy, oral
contraceptives, schizo¬
phrenia, liver disease,
anemia, genetically non-
typical ChE) have an
appreciable effect on
sensitivity to ChE-I's?
4 What relative weights
should be given to
studies with differing
results?
Various hypotheses have been
suggested but none proven  (Silver,
1974)
Some scientists (e.g. Rider, 1961)
interpret a decrease of ChE activity
over 25% below controls as an adverse
effect.  Others interpret a decrease
of ChE activity to be adverse if it
is significantly different (p < .05)
than pre-exposure values (telephone
conversation, 6/5/86, OPP scientist)
Rate (as well as magnitude) of ChE-I
has been identified as contributing
to toxicity, but currently only the
magnitude of ChE-I is used as a
measure of toxicity.
For example, a dosing schedule in a
study of malathion in humans was
unusual:  eight mg was administered
to five subjects for thirty-two days,
then no treatment was given for three
weeks, and then sixteen mg was  given
to the same subjects for forty-seven
days.  The first exposure may have
altered the response observed with
the second exposure.
It is hypothesized that individuals
with decreased ChE levels are at high
risk to ChE-I pesticides, but there
is insufficient data to establish
this.
In cancer policy, a study in which a
dose is associated with an adverse
effect (e.g., a tumor) is weighted
more than a comparable study finding
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Type*  ffpcertainty Explanation
no effect at that dose, since it is
inferred that the latter study must
have been less sensitive than the
former.  For ChE-I pesticides, a
study in which a dose is found to
exhibit no effect is weighted more
than a comparable study (same
species) showing an effect at that
dose.  The highest dose showing no
effect is considered the NOEL for
that species.
Dose'-Response Assessment
What method of dose-
response assessment
should be used?
What UF should be
selected to reduce a
NOEL observed in an
animal study to a RfU
for humans?
Currently, the NOEL-UF approach is
used by EPA, although some scientists
(e.g. Crump) advocate other methods
(e.g., BD-UF approach).
Different offices within EPA (e.g.,
OPP, ODW) have differed over the
selection of an appropriate UF (e.g.,10 or 100) .
What is the population
threshold for a ChE-I
pesticide?
What criteria should be
used to determine a NOEL
for ChE-I?
If data are available
on more than one species,
how should they be used?
The true population threshold for a
ChE-I pesticide can not be determined
with certainty, since to do so would
involve exposing a multitude of
people to the pesticide, an impractical
and socially unacceptable proposal.
Different scientists use different
criteria (e.g., magnitude of ChE-I,
site where ChE is measured, dose-
response trend) to determine a NOEL.
Although the use of the most
sensitive species is stated to be
current EPA science policy (EPA,
1986) , this is not strictly true.
The dog is the most sensitive species
to ChE-I by parathion, but is not
used since the NOEL is below the
lowest dose tested in the available
dog study.
Type*  Dncertainfy Biplanation
VA-2
Exposure Assessment
What methods of
estimating exposures of
potential high risk
groups are most accurate?
Kow should one estimate
the size, location, and
other characteristics of
the population of indiv¬
iduals with genetically
non-typical ChE?
How should dietary habits
and other variations in
lifestyle be taken into
account?
Different researchers favor differentmethods, even under the same
conditions (e.g., direct vs. indirectmonitoring methods).
Individuals with genetic variants ofChE are not readily identifiable.
Dieting, fasting, alcohol and
cigarette use, etc. can potentiallycontribute to increased
susceptibility to ChE-I pesticides.
How should one estimate
the size and nature of
the populations likely
to be exposed through
non-agricultural uses
of ChE-I pesticides?
Data on exposures from
nonagricultural uses of ChE-Ipesticides (particularly to thegeneral public) is generally
insufficient, largely because thereis no regulatory approach for
controlling these exposures, as thereis for dietary exposures (GAO, 1986)
Risk Characterization
What are the biological
uncertainties in estimat¬
ing the extent of health
effects from exposures
to ChE-I pesticides?
How should they be esti¬
mated and presented todecision makers?
The difference between fact and
opinion can be a matter of dispute.The way in which uncertainties areestimated and presented may bias thedecision maker.
What are the statistical
uncertainties in estimat¬
ing the extent of health
effects from exposures
to ChE-I pesticides?
How should they be esti¬
mated and presented todecision makers?
Statistical uncertainties are often
not estimated when assessing risks ofChE-I pesticides.  The way in whichuncertainties are presented may biasthe decision maker.
VA-3
Type* nncftftaintY
3 Which population groups
should be the primary
targets for protection?
4 Which provide the most
meaningful expression ofthe health risk?
Explanation
Should "average" consumers or highrisk groups be targeted?  Risk
management considerations factor intothe resolution of these questions.
Type codes (see text pp. V-2,  3):
Trans-scientific uncertaintyUncertainty due to insufficient data
Uncertainty due to varying scientific interpretationUncertainty due to disagreement over inferences
VA-4
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